Updated on 2025/10/18

写真a

 
WATANABE Yuichiro
 
Organization
University Medical and Dental Hospital Uonuma Institute of Community Medicine Specially Appointed Professor
Graduate School of Medical and Dental Sciences Biological Functions and Medical Control Sensory and Integrative Medicine Specially Appointed Professor
Title
Specially Appointed Professor
External link

Degree

  • 医学博士 ( 2005.3   新潟大学 )

Research Areas

  • Life Science / Psychiatry

Research History (researchmap)

  • Niigata University   Medical and Dental Hospital Uonuma Institute of Community Medicine   Specially Appointed Professor

    2023.4

      More details

  • Niigata University   Graduate School of Medical and Dental Sciences   Associate Professor

    2018.4 - 2023.3

      More details

  • Niigata University   Uonuma Institute of Community Medicine, Medical and Dental Hospital   Specially Appointed Professor

    2015.6 - 2018.3

      More details

  • Niigata University   Graduate School of Medical and Dental Sciences   Associate Professor

    2012.4 - 2015.5

      More details

  • Niigata University   Research Institute for Natural Hazards and Disaster Recovery Division of Environmental Safety Section of Disaster Medicine   Associate Professor

    2012.4 - 2015.3

      More details

  • Niigata University   Faculty of Medicine   Lecturer

    2011.11 - 2012.3

      More details

  • Niigata University   Research Institute for Natural Hazards and Disaster Recovery   Lecturer

    2011.4 - 2012.3

      More details

  • Niigata University   Headquarters for Health Administration Health Administration Center   Lecturer

    2009.4 - 2012.3

      More details

  • Niigata University   Research Center for Natural Hazards and Disaster Recovery   Lecturer

    2009.4 - 2011.3

      More details

  • Niigata University   Research Center for Natural Hazards and Disaster Recovery   Assistant Professor

    2008.5 - 2009.3

      More details

  • Niigata University   Graduate School of Medical and Dental Sciences Biological Functions and Medical Control Sensory and Integrative Medicine   Assistant Professor

    2007.12 - 2009.3

      More details

  • Niigata University   University Medical and Dental Hospital   Assistant Professor

    2005.5 - 2007.11

      More details

  • Niigata University   Brain Research Institute

    2005.4

      More details

▶ display all

Research History

  • Niigata University   Sensory and Integrative Medicine, Biological Functions and Medical Control, Graduate School of Medical and Dental Sciences   Specially Appointed Professor

    2023.4

  • Niigata University   UONUMA CHIIKI IRYO KYOIKU CENTER, University Medical and Dental Hospital   Specially Appointed Professor

    2023.4

  • Niigata University   Graduate School of Medical and Dental Sciences Biological Functions and Medical Control Sensory and Integrative Medicine   Associate Professor

    2018.4 - 2023.3

  • Niigata University   University Medical and Dental Hospital UONUMA CHIIKI IRYO KYOIKU CENTER JUNBISHITU   Specially Appointed Professor

    2015.6 - 2018.3

  • Niigata University   Faculty of Medicine School of Medicine   Associate Professor

    2012.4 - 2015.5

  • Niigata University   Research Institute for Natural Hazards and Disaster Recovery Division of Environmental Safety Section of Disaster Medicine   Associate Professor

    2012.4 - 2015.5

  • Niigata University   Graduate School of Medical and Dental Sciences   Associate Professor

    2012.4 - 2015.5

  • Niigata University   Faculty of Medicine   Lecturer

    2011.11 - 2012.3

  • Niigata University   Research Institute for Natural Hazards and Disaster Recovery   Lecturer

    2011.4 - 2012.3

  • Niigata University   Health Administration Center   Lecturer

    2009.4 - 2012.3

  • Niigata University   Research Center for Natural Hazards and Disaster Recovery   Lecturer

    2009.4 - 2011.3

  • Niigata University   Research Center for Natural Hazards and Disaster Recovery   Assistant Professor

    2008.5 - 2009.3

  • Niigata University   Graduate School of Medical and Dental Sciences Biological Functions and Medical Control Sensory and Integrative Medicine   Assistant Professor

    2007.12 - 2009.3

  • Niigata University   University Medical and Dental Hospital   Assistant Professor

    2005.5 - 2007.11

  • Niigata University   Brain Research Institute

    2005.4 - 2023.3

▶ display all

Education

  • Niigata University   Graduate School of Medical and Dental Sciences

    - 2005.3

      More details

  • Niigata University   Faculty of Medicine

    - 1998.3

      More details

Qualification acquired

  • 日本医師会認定産業医

  • 日本精神神経学会指導医

  • 日本精神神経学会専門医

  • 精神保健指定医

  • Doctor

 

Papers

  • Rare nonsynonymous germline and mosaic de novo variants in Japanese patients with schizophrenia. International journal

    Yuichiro Watanabe, Masaki Nishioka, Ryo Morikawa, Satoko Takano-Isozaki, Hirofumi Igeta, Kanako Mori, Tadafumi Kato, Toshiyuki Someya

    Psychiatry and clinical neurosciences   2024.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    AIM: Whole-exome sequencing (WES) studies have revealed that germline de novo variants (gDNVs) contribute to the genetic etiology of schizophrenia. However, the contribution of mosaic DNVs (mDNVs) to the risk of schizophrenia remains to be elucidated. In the present study, we systematically investigated the gDNVs and mDMVs that contribute to the genetic etiology of schizophrenia in a Japanese population. METHODS: We performed deep WES (depth: 460×) of 73 affected offspring and WES (depth: 116×) of 134 parents from 67 families with schizophrenia. Prioritized rare nonsynonymous gDNV and mDNV candidates were validated using Sanger sequencing and ultra-deep targeted amplicon sequencing (depth: 71,375×), respectively. Subsequently, we performed a Gene Ontology analysis of the gDNVs and mDNVs to obtain biological insights. Lastly, we selected DNVs in known risk genes for psychiatric and neurodevelopmental disorders. RESULTS: We identified 62 gDNVs and 98 mDNVs. The Gene Ontology analysis of mDNVs implicated actin filament and actin cytoskeleton as candidate biological pathways. There were eight DNVs in known risk genes: splice region gDNVs in AKAP11 and CUL1; a frameshift gDNV in SHANK1; a missense gDNV in SRCAP; missense mDNVs in CTNNB1, GRIN2A, and TSC2; and a nonsense mDNV in ZFHX4. CONCLUSION: Our results suggest the potential contributions of rare nonsynonymous gDNVs and mDNVs to the genetic etiology of schizophrenia. This is the first report of the mDNVs in schizophrenia trios, demonstrating their potential relevance to schizophrenia pathology.

    DOI: 10.1111/pcn.13758

    PubMed

    researchmap

  • Decreased oral function in Japanese inpatients with schizophrenia

    Yuichiro Watanabe, Masataka Otake, Shin Ono, Masaya Ootake, Kazuhiro Murakami, Koichiro Kumagai, Koji Matsuzawa, Hiroyuki Kasahara, Kazuhiro Hori, Toshiyuki Someya

    Neuropsychopharmacology Reports   2024.4

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    Abstract

    Aim

    Oral function in patients with schizophrenia has not been well‐characterized. To address this, we performed a cross‐sectional study of oral function in Japanese inpatients with schizophrenia.

    Methods

    We measured oral function, including occlusal force, tongue–lip motor function, tongue pressure, and masticatory function in 130 Japanese inpatients with schizophrenia. We then compared the frequency of clinical signs of oral hypofunction among 63 non‐elderly and 67 elderly inpatients with schizophrenia, as well as data from 98 elderly control participants from a previous Japanese study.

    Results

    The frequency of reduced occlusal force was significantly higher in the elderly inpatients (76.2%) than in the non‐elderly inpatients (43.9%) and elderly controls (43.9%). The frequency of decreased tongue–lip motor function in non‐elderly inpatients (96.8%) and elderly inpatients (97.0%) was significantly higher than that in elderly controls (56.1%). The frequency of decreased tongue pressure in non‐elderly inpatients (66.1%) and elderly inpatients (80.7%) was significantly higher than that in elderly controls (43.9%). Finally, the frequency of decreased masticatory function was highest in elderly inpatients (76.5%), followed by non‐elderly inpatients (54.8%) and elderly controls (15.3%).

    Conclusion

    Oral function was decreased in both non‐elderly and elderly Japanese inpatients with schizophrenia compared with elderly controls.

    DOI: 10.1002/npr2.12443

    researchmap

  • Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case-control study. International journal

    Tzuyao Lo, Itaru Kushima, Hiroki Kimura, Branko Aleksic, Takashi Okada, Hidekazu Kato, Toshiya Inada, Yoshihiro Nawa, Youta Torii, Maeri Yamamoto, Ryo Kimura, Yasuko Funabiki, Hirotaka Kosaka, Shusuke Numata, Kiyoto Kasai, Tsukasa Sasaki, Shigeru Yokoyama, Toshio Munesue, Ryota Hashimoto, Yuka Yasuda, Michiko Fujimoto, Masahide Usami, Masanari Itokawa, Makoto Arai, Kazutaka Ohi, Toshiyuki Someya, Yuichiro Watanabe, Jun Egawa, Tsutomu Takahashi, Michio Suzuki, Hidenori Yamasue, Nakao Iwata, Masashi Ikeda, Norio Ozaki

    Neuropsychopharmacology reports   44 ( 1 )   42 - 50   2024.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    AIM: The present study aimed to examine the association between copy number variations (CNVs) in parkin (PRKN) and schizophrenia (SCZ) and autism spectrum disorder (ASD) in a large case-control sample. METHOD: Array comparative genomic hybridization was performed on 3111 cases with SCZ, 1236 cases with ASD, and 2713 controls. We systematically prioritized likely pathogenic CNVs (LP-CNVs) in PRKN and examined their association with SCZ and ASD. RESULTS: In total, 3014 SCZ cases (96.9%), 1205 ASD cases (97.5%), and 2671 controls (98.5%) passed quality control. We found that monoallelic carriers of LP-CNVs in PRKN were common (70/6890, 1.02%) and were not at higher risk of SCZ (p = 0.29) or ASD (p = 0.72). We observed that the distribution pattern of LP-CNVs in the Japanese population was consistent with those in other populations. We also identified a patient diagnosed with SCZ and early-onset Parkinson's disease carrying biallelic pathogenic CNVs in PRKN. The absence of Parkinson's symptoms in 10 other monoallelic carriers of the same pathogenic CNV further reflects the lack of effect of monoallelic pathogenic variants in PRKN in the absence of a second hit. CONCLUSION: The present findings suggest that monoallelic CNVs in PRKN do not confer a significant risk for SCZ or ASD. However, further studies to investigate the association between biallelic CNVs in PRKN and SCZ and ASD are warranted.

    DOI: 10.1002/npr2.12370

    PubMed

    researchmap

  • Usefulness of the autism spectrum quotient (AQ) in screening for autism spectrum disorder and social communication disorder. International journal

    Kiyohiro Yoshinaga, Jun Egawa, Yuichiro Watanabe, Hiroyuki Kasahara, Atsunori Sugimoto, Toshiyuki Someya

    BMC psychiatry   23 ( 1 )   831 - 831   2023.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: In the Diagnostic and Statistical Manual and Mental Disorders, Fifth Edition (DSM-5), autism spectrum disorder (ASD) and social (pragmatic) communication disorder (SCD) were described as a new category of psychiatry nosography. SCD involves impairments in social communication and social interaction but not restricted, repetitive patterns of behavior, interests, or activities. The autism spectrum quotient (AQ) was developed to screen for autism tendencies in adults with normal intelligence. However, AQ cutoff scores for screening ASD and SCD in the DSM-5 have not been established. This study examined whether the Japanese version of the AQ (AQ-J) total scores could discriminate between an ASD group, an SCD group, and a neurotypical (NT) group. METHODS: Participants were 127 ASD patients, 52 SCD patients, and 49 NT individuals. Receiver operating characteristic (ROC) analyses were used to examine AQ-J total score cutoff values to distinguish between ASD and NT groups, SCD and NT groups, and ASD and SCD groups. RESULTS: In the ROC analysis for the ASD and NT groups, the area under the curve (AUC) was 0.96, and the optimum cutoff value was 23 points (sensitivity 92.9%, specificity 85.7%). The AUC for the SCD and NT groups was 0.89, and the optimum cutoff value was 22 points (sensitivity 84.6%, specificity 85.7%). The AUC for the ASD and SCD groups was 0.75; the optimum cutoff value was 32 points (sensitivity 67.7%, specificity 71.2%). CONCLUSION: Our findings suggest the usefulness of the AQ-J in screening for ASD and SCD.

    DOI: 10.1186/s12888-023-05362-y

    PubMed

    researchmap

  • The three-factor structure of the Autism-Spectrum Quotient Japanese version in pregnant women

    Ekachaeryanti Zain, Naoki Fukui, Yuichiro Watanabe, Koyo Hashijiri, Takaharu Motegi, Maki Ogawa, Jun Egawa, Koji Nishijima, Toshiyuki Someya

    Frontiers in Psychiatry   14   2023.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Frontiers Media SA  

    Background

    There is a rising interest in perinatal mental health studies, and proper psychometric tools to assess autistic traits among this population in Japan are vital.

    Objective

    This study aimed to clarify the optimal factor structure of the AQ as part of a perinatal mental health research project.

    Methods

    We used the Japanese version of the AQ (AQ-J) to measure autistic-like traits in pregnant women. Participants were 4,287 Japanese women who were pregnant or who had given birth within the last month. We performed exploratory factor analysis (EFA) using the first sample group (n = 2,154) to obtain factor structures for the final item selections. We performed confirmatory factor analysis (CFA) using the second sample group (n = 2,133) to obtain a model with good fit, then compared the model to all previously proposed models to determine the best-fitting model.

    Results

    The EFA analysis identified a model consisting of 25 items distributed across three factors. Cronbach’s alpha for the total 25-item AQ-J, 9-item “Social interaction” factor, 11-item “Non-verbal communication” factor, and 5-item “Restricted interest” factor was 0.829, 0.829, 0.755, and 0.576, respectively. McDonald’s omega and its 95% confidence interval were 0.826 (0.821–0.836), 0.835 (0.821–0.837), 0.755 (0.744–0.766), and 0.603 (0.556–0.596), respectively. CFA confirmed that the three-factor structure had an acceptable fit (goodness of fit index: 0.900, comparative fit index: 0.860, root mean square error of approximation: 0.066). These findings indicated that the three-factor model was better than the 13 existing models.

    Conclusion

    The findings are discussed in relation to the adequacy of the AQ-J for assessing autistic traits in perinatal women. We recommend the use of this 25-item, three-factor AQ-J model for this population owing to its superiority to all previous models.

    DOI: 10.3389/fpsyt.2023.1275043

    researchmap

  • Association between insulin resistance and serum insulin-like growth factor 1 levels in patients with non-remitting major depressive disorder. International journal

    Hiroshi Arinami, Yutaro Suzuki, Yuichiro Watanabe, Misuzu Tajiri, Nobuto Tsuneyama, Toshiyuki Someya

    Journal of affective disorders   2023.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Major depressive disorder (MDD) is linked to an increased risk of diabetes; however, the underlying pathomechanism remains unknown. Although insulin-like growth factor 1 (IGF-1) is involved in the pathogenesis of both insulin resistance (IR) and MDD, no studies have investigated the relationship between IGF-1 and IR in patients with MDD. METHODS: We recruited 120 patients with MDD (84 non-remitting patients and 36 remitting patients) and 99 control participants. Blood samples were collected after overnight fasting to investigate associations between serum and clinical factors, such as serum IGF-1 levels and homeostasis model assessment-insulin resistance (HOMA-IR). RESULTS: Serum IGF-1 levels were higher in patients with non-remitting MDD than in control participants and patients with remitting MDD (P = 0.001 and P = 0.007, respectively). There were no significant differences in HOMA-IR between the three groups. HOMA-IR was positively correlated with serum IGF-1 levels in patients with non-remitting MDD (R = 0.355; P= 0.001) but not in control participants or patients with remitting MDD. A stepwise multiple regression analysis with various clinical factors revealed a positive association of serum IGF-1 levels and body mass index with HOMA-IR in patients with non-remitting MDD. LIMITATIONS: This is a cross-sectional study and therefore we cannot draw firm conclusions about causal associations. CONCLUSIONS: Serum IGF-1 levels may play a role in IR in patients with MDD who fail to achieve remission. Further studies, including longitudinal studies, are needed to determine the relationship between high serum IGF-1 levels and subsequent IR and diabetes risk.

    DOI: 10.1016/j.jad.2023.10.009

    PubMed

    researchmap

  • High care and low overprotection from both paternal and maternal parents predict a secure attachment style with a partner among perinatal Japanese women

    Ekachaeryanti Zain, Naoki Fukui, Yuichiro Watanabe, Koyo Hashijiri, Takaharu Motegi, Maki Ogawa, Jun Egawa, Toshiyuki Someya

    Scientific Reports   13 ( 1 )   2023.9

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    This study aimed to determine how paternal and maternal parenting before adolescence affects adult attachment to a partner during the perinatal period, using three different models of attachment. We used the Parental Bonding Instrument (PBI) and the Relationship Questionnaire (RQ) to examine perceived parenting practices and adult attachment styles, respectively. The participants included 4586 Japanese women who were pregnant or who had given birth, up until one month after childbirth. We performed structural equation modeling analysis between PBI and RQ scores with three different category models, including the four-category model (secure, fearful, preoccupied, and dismissive attachment) as Model 1, the two-category model (model of the self and others) as Model 2, and the single-category model (total attachment style) as Model 3. Models 1 and 2 showed a good fit. Both path models showed a significant association between adult attachment style and perceived paternal and maternal parenting before adolescence, where high care and low overprotection from both paternal and maternal parents predicted adult attachment. Our findings indicate that attachment styles are best described using the four-category and two-category models, and suggest that both paternal and maternal overprotection and care influence adult attachment with a partner during the perinatal period.

    DOI: 10.1038/s41598-023-42674-1

    researchmap

    Other Link: https://www.nature.com/articles/s41598-023-42674-1

  • Relationships among autistic traits, depression, anxiety, and maternal–infant bonding in postpartum women

    Naoki Fukui, Yuichiro Watanabe, Takaharu Motegi, Koyo Hashijiri, Maki Ogawa, Jun Egawa, Takayuki Enomoto, Toshiyuki Someya

    BMC Psychiatry   23 ( 1 )   2023.6

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Background

    Although several studies have found significant relationships between autistic traits and depression/anxiety, the relationships between autistic traits and postpartum depression/anxiety remain unclear. Moreover, few studies have examined the relationships between autistic traits and mother–infant bonding while considering depression or anxiety.

    Methods

    This study used a cross-sectional data analysis design. Participants were 2692 women who completed the Autism-Spectrum Quotient (AQ), Hospital Anxiety and Depression Scale (HADS), and Mother-to-Infant Bonding Scale (MIBS) at 1 month postpartum. We performed path analysis that included parity, the five AQ subscales (social skills, attention switching, attention to detail, communication, and imagination), both HADS subscales (anxiety and depression), and the two MIBS subscales (lack of affection and anger and rejection).

    Results

    Our path analysis revealed that higher scores for social skills, attention switching, communication, and imagination were associated with higher scores for depression. Higher scores for social skills, attention switching, attention to detail, and communication were associated with higher scores for anxiety. Moreover, difficulties in social skills and imagination were associated with failure of maternal–infant bonding. However, more attention to detail was associated with better maternal–infant bonding.

    Conclusions

    This study suggests that maternal autistic traits are related to anxiety and depression to a certain degree, but only slightly related to maternal–infant bonding at 1 month postpartum. To improve autistic women’s quality of life and that of their newborns, perinatal mental health issues such as anxiety, depression, and maternal–fetal bonding difficulties should be appropriately addressed.

    DOI: 10.1186/s12888-023-04970-y

    researchmap

    Other Link: https://link.springer.com/article/10.1186/s12888-023-04970-y/fulltext.html

  • Serum cortisol and insulin-like growth factor 1 levels in major depressive disorder and schizophrenia. International journal

    Hiroshi Arinami, Yuichiro Watanabe, Yutaro Suzuki, Misuzu Tajiri, Nobuto Tsuneyama, Toshiyuki Someya

    Scientific reports   13 ( 1 )   1148 - 1148   2023.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The pathophysiology underlying major depressive disorder (MDD) and schizophrenia is related to endocrine system functions and includes changes in the blood levels of cortisol and insulin-like growth factor 1 (IGF-1). However, these hormones have not been investigated simultaneously in patients with MDD and schizophrenia. We investigated the differences in serum cortisol and IGF-1 levels among patients with MDD and schizophrenia and controls. We included 129 patients with MDD, 71 patients with schizophrenia, and 71 healthy volunteers. Blood tests were performed between 6:00 am and 11:00 am after fasting. Serum cortisol levels were significantly higher in patients with schizophrenia than in patients with MDD and controls. Serum cortisol levels were significantly higher in patients with MDD than in controls. Serum IGF-1 levels were higher in both patient groups than in controls, whereas there was no significant difference between patients with MDD and schizophrenia. Both cortisol and IGF-1 levels were positively correlated with the Hamilton Rating Scale for Depression score in patients with MDD, whereas cortisol level was positively correlated and IGF-1 level was negatively correlated with the Brief Psychiatric Rating Scale score in patients with schizophrenia. The differences in the level of these hormones suggest pathophysiological differences between these disorders.

    DOI: 10.1038/s41598-023-28449-8

    PubMed

    researchmap

  • Factor structure of the parental bonding instrument for pregnant Japanese women. International journal

    Naoki Fukui, Yuichiro Watanabe, Koyo Hashijiri, Takaharu Motegi, Maki Ogawa, Jun Egawa, Takayuki Enomoto, Toshiyuki Someya

    Scientific reports   12 ( 1 )   19071 - 19071   2022.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The parental bonding instrument (PBI) is often used to examine the perceptions of children and adolescents regarding parenting practices. Previous studies have investigated the factor structure of the PBI. However, although it is important to examine the relationships between the perceived parenting practices and perinatal mental health, few studies have included perinatal women. We aimed to accurately clarify which PBI factor structure was useful in assessing perinatal women (n = 4633). Furthermore, we evaluated the measurement invariance between primipara and multipara groups, and between the paternal and maternal PBI forms. Our exploratory and confirmatory factor analyses revealed that a three-factor PBI structure was most plausible for perinatal women. Moreover, we found complete invariance (residual invariance) of the PBI ratings across primipara and multipara women for the paternal and maternal forms. In contrast, we found weak invariance (metric invariance) of the PBI ratings across the paternal and maternal forms. Our participants tended to rate fathers as less caring and less overprotective than mothers. This three-factor structure shows measurement invariance in perinatal women and can be used to accurately determine how the perceived parenting style before adolescence influences women's mental health in the perinatal period.

    DOI: 10.1038/s41598-022-22017-2

    PubMed

    researchmap

  • Clinical manifestations of schizophrenia in four patients with variants in voltage-gated calcium channel-encoding genes: a case series. International journal

    Tzuyao Lo, Itaru Kushima, Branko Aleksic, Akira Yoshimi, Toshiyuki Someya, Yuichiro Watanabe, Norio Ozaki

    Psychiatry and clinical neurosciences   77 ( 1 )   57 - 59   2022.10

     More details

    Language:English  

    DOI: 10.1111/pcn.13494

    PubMed

    researchmap

  • Associations between the number of antipsychotics prescribed and metabolic parameters in Japanese patients with schizophrenia

    Yuichiro Watanabe, Shin Ono, Takuro Sugai, Yutaro Suzuki, Manabu Yamazaki, Norio Sugawara, Norio Yasui‐Furukori, Kazutaka Shimoda, Takao Mori, Yuji Ozeki, Hiroshi Matsuda, Kurefu Okamoto, Toyoaki Sagae, Toshiyuki Someya

    Psychiatry and Clinical Neurosciences Reports   1 ( 3 )   2022.7

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1002/pcn5.28

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/pcn5.28

  • A case presenting with a major depressive episode with palilalia and difficulty opening eyes as prodromal symptoms of progressive supranuclear palsy

    Koji Matsuzawa, Yuichi Yokoyama, Yuichiro Watanabe, Takahiro Wakasugi, Toshiyuki Someya

    Psychiatry and Clinical Neurosciences Reports   1 ( 2 )   2022.6

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1002/pcn5.24

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/pcn5.24

  • Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder. International journal

    Itaru Kushima, Masahiro Nakatochi, Branko Aleksic, Takashi Okada, Hiroki Kimura, Hidekazu Kato, Mako Morikawa, Toshiya Inada, Kanako Ishizuka, Youta Torii, Yukako Nakamura, Satoshi Tanaka, Miho Imaeda, Nagahide Takahashi, Maeri Yamamoto, Kunihiro Iwamoto, Yoshihiro Nawa, Nanayo Ogawa, Shuji Iritani, Yu Hayashi, Tzuyao Lo, Gantsooj Otgonbayar, Sho Furuta, Nakao Iwata, Masashi Ikeda, Takeo Saito, Kohei Ninomiya, Tomo Okochi, Ryota Hashimoto, Hidenaga Yamamori, Yuka Yasuda, Michiko Fujimoto, Kenichiro Miura, Masanari Itokawa, Makoto Arai, Mitsuhiro Miyashita, Kazuya Toriumi, Kazutaka Ohi, Toshiki Shioiri, Kiyoyuki Kitaichi, Toshiyuki Someya, Yuichiro Watanabe, Jun Egawa, Tsutomu Takahashi, Michio Suzuki, Tsukasa Sasaki, Mamoru Tochigi, Fumichika Nishimura, Hidenori Yamasue, Hitoshi Kuwabara, Tomoyasu Wakuda, Takahiro A Kato, Shigenobu Kanba, Hideki Horikawa, Masahide Usami, Masaki Kodaira, Kyota Watanabe, Takeo Yoshikawa, Tomoko Toyota, Shigeru Yokoyama, Toshio Munesue, Ryo Kimura, Yasuko Funabiki, Hirotaka Kosaka, Minyoung Jung, Kiyoto Kasai, Tempei Ikegame, Seiichiro Jinde, Shusuke Numata, Makoto Kinoshita, Tadafumi Kato, Chihiro Kakiuchi, Kazuhiro Yamakawa, Toshimitsu Suzuki, Naoki Hashimoto, Shuhei Ishikawa, Bun Yamagata, Shintaro Nio, Toshiya Murai, Shuraku Son, Yasuto Kunii, Hirooki Yabe, Masumi Inagaki, Yu-Ichi Goto, Yuto Okumura, Tomoya Ito, Yuko Arioka, Daisuke Mori, Norio Ozaki

    Biological psychiatry   92 ( 5 )   362 - 374   2022.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: We aimed to determine the similarities and differences in the roles of genic and regulatory copy number variations (CNVs) in bipolar disorder (BD), schizophrenia (SCZ), and autism spectrum disorder (ASD). METHODS: Based on high-resolution CNV data from 8708 Japanese samples, we performed to our knowledge the largest cross-disorder analysis of genic and regulatory CNVs in BD, SCZ, and ASD. RESULTS: In genic CNVs, we found an increased burden of smaller (<100 kb) exonic deletions in BD, which contrasted with the highest burden of larger (>500 kb) exonic CNVs in SCZ/ASD. Pathogenic CNVs linked to neurodevelopmental disorders were significantly associated with the risk for each disorder, but BD and SCZ/ASD differed in terms of the effect size (smaller in BD) and subtype distribution of CNVs linked to neurodevelopmental disorders. We identified 3 synaptic genes (DLG2, PCDH15, and ASTN2) as risk factors for BD. Whereas gene set analysis showed that BD-associated pathways were restricted to chromatin biology, SCZ and ASD involved more extensive and similar pathways. Nevertheless, a correlation analysis of gene set results indicated weak but significant pathway similarities between BD and SCZ or ASD (r = 0.25-0.31). In SCZ and ASD, but not BD, CNVs were significantly enriched in enhancers and promoters in brain tissue. CONCLUSIONS: BD and SCZ/ASD differ in terms of CNV burden, characteristics of CNVs linked to neurodevelopmental disorders, and regulatory CNVs. On the other hand, they have shared molecular mechanisms, including chromatin biology. The BD risk genes identified here could provide insight into the pathogenesis of BD.

    DOI: 10.1016/j.biopsych.2022.04.003

    PubMed

    researchmap

  • Novel missense SETD1A variants in Japanese patients with schizophrenia: Resequencing and association analysis. International journal

    Ryo Morikawa, Yuichiro Watanabe, Hirofumi Igeta, Reza K Arta, Masashi Ikeda, Satoshi Okazaki, Satoshi Hoya, Takeo Saito, Ikuo Otsuka, Jun Egawa, Takaki Tanifuji, Nakao Iwata, Toshiyuki Someya

    Psychiatry research   310   114481 - 114481   2022.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    SETD1A has been identified as a substantial risk gene for schizophrenia. To further investigate the role of SETD1A in the genetic etiology of schizophrenia in the Japanese population, we performed resequencing and association analyses. First, we resequenced the SETD1A coding regions of 974 patients with schizophrenia. Then, we genotyped variants, prioritized via resequencing, in 2,027 patients with schizophrenia and 2,664 controls. Next, we examined the association between SETD1A and schizophrenia in 3,001 patients with schizophrenia and 2,664 controls. Finally, we performed a retrospective chart review of patients with prioritized SETD1A variants. We identified two novel missense variants (p.Ser575Pro and p.Glu857Gln) via resequencing. We did not detect these variants in 4,691 individuals via genotyping. These variants were not significantly associated with schizophrenia in the association analysis. Additionally, we found that a schizophrenia patient with the p.Glu857Gln variant had developmental delays. In conclusion, novel SETD1A missense variants were exclusively identified in Japanese patients with schizophrenia. However, our study does not provide evidence for the contribution of these variants to the genetic etiology of schizophrenia in the Japanese population.

    DOI: 10.1016/j.psychres.2022.114481

    PubMed

    researchmap

  • Polymorphisms in the hypoxia inducible factor binding site of the macrophage migration inhibitory factor gene promoter in schizophrenia. International journal

    Satoshi Okazaki, Shuken Boku, Yuichiro Watanabe, Ikuo Otsuka, Tadasu Horai, Ryo Morikawa, Atsushi Kimura, Naofumi Shimmyo, Takaki Tanifuji, Toshiyuki Someya, Akitoyo Hishimoto

    PloS one   17 ( 3 )   e0265738   2022

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine that promotes neurogenesis and neuroprotection. MIF is predominantly expressed in astrocytes in the brain. The serum MIF level and microsatellites/single nucleotide polymorphisms (SNPs) in the MIF gene promoter region are known to be associated with schizophrenia (SCZ). Interestingly, previous studies reported that hypoxia, an environmental risk factor for SCZ, induced MIF expression through binding of the hypoxia inducible factor (HIF)-1 to the hypoxia response element (HRE) in the MIF promoter. METHODS: We investigated the involvement of MIF in SCZ while focusing on the HIF pathway. First, we conducted an association study of the SNP rs17004038 (C>A) in the HRE of the MIF promoter between 1758 patients with SCZ and 1507 controls. Next, we investigated the effect of hypoxia on MIF expression in primary cultured astrocytes derived from neonatal mice forebrain. RESULTS: SNP rs17004038 was significantly associated with SCZ (p = 0.0424, odds ratio = 1.445), indicating that this SNP in the HRE of the MIF promoter was a genetic risk factor for SCZ. Hypoxia induced MIF mRNA expression and MIF protein production and increased HIF-1 binding to the MIF promoter, while the activity of the MIF promoter was suppressed by mutations in the HRE and by deletion of the HRE in astrocytes. CONCLUSION: These results suggest that SNP rs17004038 in the HRE of the MIF promoter was significantly associated with SCZ and may be involved in the pathophysiology of SCZ via suppression of hypoxia and HIF pathway-induced MIF expression.

    DOI: 10.1371/journal.pone.0265738

    PubMed

    researchmap

  • Association Between the Number of Remaining Teeth and Body Mass Index in Japanese Inpatients with Schizophrenia. International journal

    Masataka Otake, Shin Ono, Yuichiro Watanabe, Koichiro Kumagai, Koji Matsuzawa, Hiroyuki Kasahara, Masaya Ootake, Takuro Sugai, Toshiyuki Someya

    Neuropsychiatric disease and treatment   18   2591 - 2597   2022

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: There is little evidence regarding the effects of dental status on body mass index (BMI) in inpatients with schizophrenia. Thus, we performed a cross-sectional study to explore the associations between the number of remaining teeth and BMI in Japanese inpatients with schizophrenia. PATIENTS AND METHODS: We performed multiple regression analysis to assess the effects of potential predictors (age, sex, number of remaining teeth, number of antipsychotics prescribed, chlorpromazine equivalent dose, and antipsychotic type) on BMI in 212 inpatients with schizophrenia. We then compared the number of remaining teeth between inpatients with schizophrenia and the Japanese general population (3283 individuals) from the Japan Dental Diseases Survey 2016, using an analysis of covariance with age and sex as covariates. RESULTS: Multiple regression analysis showed that the number of remaining teeth and the number of antipsychotics prescribed were significantly correlated with BMI (standardized regression coefficient = 0.201 and 0.235, respectively). In the analysis of covariance, inpatients with schizophrenia had significantly fewer remaining teeth compared with the Japanese general population (mean 14.8 [standard deviation: 10.9] vs mean 23.0 [standard deviation: 8.1]). CONCLUSION: These results suggested that tooth loss and antipsychotic polypharmacy affect BMI in inpatients with schizophrenia, and that inpatients with schizophrenia lose more teeth compared with the general population.

    DOI: 10.2147/NDT.S387724

    PubMed

    researchmap

  • Perceived parenting before adolescence and parity have direct and indirect effects via depression and anxiety on maternal-infant bonding in the perinatal period. International journal

    Naoki Fukui, Takaharu Motegi, Yuichiro Watanabe, Koyo Hashijiri, Ryusuke Tsuboya, Maki Ogawa, Takuro Sugai, Jun Egawa, Takayuki Enomoto, Toshiyuki Someya

    Psychiatry and clinical neurosciences   75 ( 10 )   312 - 317   2021.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    AIM: This study was aimed towards detecting how perceived parenting practices before adolescence affect maternal-infant bonding in the perinatal period, considering factors such as depression, anxiety, and parity. METHODS: We used the Parental Bonding Instrument (PBI) to examine perceived parenting practices. Participants included 1301 pregnant women who completed the Hospital Anxiety and Depression Scale (HADS) and Mother-to-Infant Bonding Scale (MIBS) at three time points: early pregnancy (approximately 12-15 weeks), late pregnancy (approximately 30-34 weeks) and postpartum (4 weeks after childbirth). We performed a path analysis with factors including parity, PBI subscales (paternal care, paternal overprotection, maternal care and maternal overprotection), HADS and MIBS. RESULTS: Perceived paternal or maternal low care parenting predicted higher HADS and MIBS scores in early pregnancy. Moreover, perceived maternal low care parenting predicted higher HADS scores at postpartum and higher MIBS scores in late pregnancy. Perceived paternal or maternal overprotective parenting predicted higher HADS scores in the pregnancy period. Furthermore, perceived maternal overprotective parenting predicted higher MIBS scores in late pregnancy. Being primipara predicted higher HADS scores at postpartum and higher MIBS scores in early pregnancy and at postpartum. Being multipara predicted higher MIBS scores in late pregnancy. CONCLUSION: This study suggests that perceived negative parenting before adolescence has indirect effects (via anxiety and depression) and direct effects on maternal-infant bonding in the perinatal period.

    DOI: 10.1111/pcn.13289

    PubMed

    researchmap

  • Exclusive Breastfeeding Is Not Associated with Maternal-Infant Bonding in Early Postpartum, Considering Depression, Anxiety, and Parity. International journal

    Naoki Fukui, Takaharu Motegi, Yuichiro Watanabe, Koyo Hashijiri, Ryusuke Tsuboya, Maki Ogawa, Takuro Sugai, Jun Egawa, Takayuki Enomoto, Toshiyuki Someya

    Nutrients   13 ( 4 )   2021.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    It is important to clarify how the breastfeeding method affects women's mental health, and how women's mental health affects the breastfeeding method in the early postpartum period when major depression and other psychiatric problems are most likely to occur. This study aimed to examine this bidirectional relationship in the early postpartum period. Participants were 2020 postpartum women who completed the Hospital Anxiety and Depression Scale (HADS) and Mother-to-Infant Bonding Scale (MIBS). We obtained data for participants' breastfeeding method for four weeks after childbirth. We performed a path analysis with factors including breastfeeding method (exclusive breastfeeding or non-exclusive breastfeeding), parity (primipara or multipara), the two HADS subscales (anxiety and depression), and the two MIBS subscales (lack of affection and anger and rejection). The path analysis showed that breastfeeding method did not significantly affect depression, anxiety, and maternal-infant bonding in the early postpartum period. Women with higher anxiety tended to use both formula-feeding and breastfeeding. Our study suggests that exclusive breastfeeding is not associated with maternal-fetal bonding in early postpartum, considering depression, anxiety, and parity.

    DOI: 10.3390/nu13041184

    PubMed

    researchmap

  • Resequencing and association analysis of GAP43 with autism spectrum disorder and schizophrenia in a Japanese population

    Reza K. Arta, Yuichiro Watanabe, Emiko Inoue, Yoshihiro Nawa, Ryo Morikawa, Jun Egawa, Itaru Kushima, Hirofumi Igeta, Satoshi Hoya, Atsunori Sugimoto, Andi J. Tanra, Norio Ozaki, Toshiyuki Someya

    RESEARCH IN AUTISM SPECTRUM DISORDERS   82   2021.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.rasd.2021.101729

    Web of Science

    researchmap

  • 【コロナ時代の自殺対策】COVID-19パンデミックと医療従事者のメンタルヘルス

    渡部 雄一郎, 染矢 俊幸

    公衆衛生   85 ( 3 )   156 - 159   2021.3

     More details

    Language:Japanese   Publisher:(株)医学書院  

    researchmap

  • Factor Structure and Measurement Invariance of the Hospital Anxiety and Depression Scale Across the Peripartum Period Among Pregnant Japanese Women. International journal

    Maki Ogawa, Yuichiro Watanabe, Takaharu Motegi, Naoki Fukui, Koyo Hashijiri, Ryusuke Tsuboya, Takuro Sugai, Jun Egawa, Rie Araki, Kazufumi Haino, Masayuki Yamaguchi, Koji Nishijima, Takayuki Enomoto, Toshiyuki Someya

    Neuropsychiatric disease and treatment   17   221 - 227   2021

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose: The Hospital Anxiety and Depression Scale (HADS) is a self-report questionnaire widely used to assess anxiety and depression. To the best of our knowledge, only four studies have examined the factor structure of the HADS for assessing pregnant women, with conflicting results. This study aimed to assess the factor structure and measurement invariance of the HADS for use with pregnant Japanese women. Participants and Methods: A total of 936 pregnant Japanese women completed the HADS questionnaire at three time points: the first and third trimester of pregnancy, and postpartum. We examined the factor structure of the HADS in Group 1 (n = 466) using exploratory factor analysis (EFA). We then compared the models identified in Group 1 with those from previous studies using confirmatory factor analysis (CFA) in Group 2 (n = 470). We performed multiple-group CFA for Group 2 to test the measurement invariance of the best-fit model across the three time points. Results: The EFA for the Group 1 data at the three time points revealed a two-factor model. In the CFA, the two-factor model from Group 1 showed the best fit with the data at the three time points. In the multiple-group CFA for Group 2, we confirmed the configural and metric invariance of the two-factor model across the three time points. Conclusion: Our findings provide evidence for a two-factor structure and weak measurement invariance of the HADS in pregnant Japanese women during the peripartum period.

    DOI: 10.2147/NDT.S294918

    PubMed

    researchmap

  • Identification of Bonding Difficulties in the Peripartum Period Using the Mother-to-Infant Bonding Scale-Japanese Version and Its Tentative Cutoff Points. International journal

    Koyo Hashijiri, Yuichiro Watanabe, Naoki Fukui, Takaharu Motegi, Maki Ogawa, Jun Egawa, Takayuki Enomoto, Toshiyuki Someya

    Neuropsychiatric disease and treatment   17   3407 - 3413   2021

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose: Identification of pregnant women with bonding difficulties is important to provide early intervention. However, few studies have examined the utility of self-report questionnaires that assess mother-infant bonding as screening tools for bonding difficulties. This longitudinal study aimed to identify pregnant women with bonding difficulties using the Japanese version of the Mother-to-Infant Bonding Scale (MIBS-J) and to estimate its optimal cutoff points in the peripartum period. Patients and Methods: A total of 1301 pregnant women completed the MIBS-J and Hospital Anxiety and Depression Scale (HADS) at three time points: first trimester (T1; approximately 12-15 weeks gestation), third trimester (T2; approximately 30-34 weeks gestation), and postpartum (T3; approximately 4 weeks postpartum). A two-step cluster analysis was conducted to classify pregnant women based on their MIBS-J subscale scores at the three time points. Based on the cluster analysis results, receiver operating characteristic curve analysis was performed to estimate the optimal cutoff scores for the MIBS-J total score at each time point. Results: The two-step cluster analysis produced two clusters: Cluster 1 (n = 824) and Cluster 2 (n = 477). Both the MIBS-J and HADS scores were significantly higher in Cluster 2 than in Cluster 1 at all time points. The MIBS-J tentative cutoff points were 3/4, 3/4, and 2/3 at T1, T2, and T3, respectively. Conclusion: We identified two distinct groups across the perinatal period: pregnant women with bonding difficulties and pregnant women with normal bonding. Our findings suggest the usefulness of the MIBS-J as a screening tool to identify bonding difficulties during pregnancy.

    DOI: 10.2147/NDT.S336819

    PubMed

    researchmap

  • The relationship between schizophrenia patients' attitudes towards physical health and the prevalence of metabolic syndrome

    Takuro Sugai, Yutaro Suzuki, Manabu Yamazaki, Norio Sugawara, Norio Yasui-Furukori, Kazutaka Shimoda, Takao Mori, Yuji Ozeki, Yuichiro Watanabe, Hiroshi Matsuda, Kurefu Okamoto, Toyoaki Sagae, Toshiyuki Someya

    Clinical Neuropsychopharmacology and Therapeutics   11 ( 0 )   23 - 34   2020.5

     More details

    Publishing type:Research paper (scientific journal)   Publisher:The Japanese Society of Clinical Neuropsychopharmacology  

    DOI: 10.5234/cnpt.11.23

    researchmap

  • Whole-exome sequencing in a family with a monozygotic twin pair concordant for schizophrenia and a follow-up case-control study of identified de-novo variants. Reviewed International journal

    Satoshi Hoya, Yuichiro Watanabe, Ayako Nunokawa, Ikuo Otsuka, Masako Shibuya, Hirofumi Igeta, Akitoyo Hishimoto, Toshiyuki Someya

    Psychiatric genetics   30 ( 2 )   60 - 63   2020.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Whole-exome sequencing (WES) studies have shown that de-novo variants contribute to the genetic etiology of schizophrenia. WES studies of families with a monozygotic twin pair concordant or discordant for a disease may be fruitful for identifying de-novo pathogenic variants. Here, we performed WES in six individuals from one family (affected monozygotic twins, their unaffected parents, and two siblings) and identified three de-novo missense variants (CPT2 Ala283Thr, CPSF3 Val584Ile, and RNF148 Val210Ile) in the monozygotic twin pair concordant for schizophrenia. These three missense variants were not found in 1760 patients with schizophrenia or schizoaffective disorder or 1508 healthy controls. Our data do not support the role of the three missense variants in conferring risk for schizophrenia.

    DOI: 10.1097/YPG.0000000000000250

    PubMed

    researchmap

  • Depression, Anxiety and Primiparity are Negatively Associated with Mother-Infant Bonding in Japanese Mothers. International journal

    Takaharu Motegi, Yuichiro Watanabe, Naoki Fukui, Maki Ogawa, Koyo Hashijiri, Ryusuke Tsuboya, Takuro Sugai, Jun Egawa, Rie Araki, Kazufumi Haino, Masayuki Yamaguchi, Koji Nishijima, Takayuki Enomoto, Toshiyuki Someya

    Neuropsychiatric disease and treatment   16   3117 - 3122   2020

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose: Postpartum depression is a well-known risk factor, and postpartum anxiety and parity are potential risk factors, for mother-infant bonding disorder. However, few studies have focused on the relationships among these factors and mother-infant bonding. This cross-sectional study explored the associations between depression, anxiety and parity, and mother-infant bonding. Materials and Methods: Japanese mothers, both primiparas and multiparas, completed the Mother-to-Infant Bonding Scale (MIBS) and the Hospital Anxiety and Depression Scale (HADS) one month after childbirth. We performed a stepwise multiple regression analysis with the forward selection method to assess the effects of HADS anxiety and depression scores and parity as independent variables on mother-infant bonding as the dependent variable. Results: A total of 2379 Japanese mothers (1116 primiparas and 1263 multiparas) took part in the study. MIBS score (2.89 ± 2.68 vs 1.60 ± 2.11; p < 0.0001) was significantly higher in primiparas than in multiparas. HADS anxiety (6.55 ± 4.06 vs 4.63 ± 3.41; p < 0.0001) and depression (6.56 ± 3.43 vs 5.98 ± 3.20; p < 0.0001) scores were also significantly higher in primiparas than in multiparas. A stepwise multiple regression analysis with the forward selection method revealed that HADS depression and anxiety scores and parity were significantly associated with MIBS score (p = 0.003, 0.015 and 0.023). Conclusion: Depression, anxiety and primiparity were negatively associated with mother-infant bonding one month after childbirth.

    DOI: 10.2147/NDT.S287036

    PubMed

    researchmap

  • Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect. Reviewed International journal

    Masashi Ikeda, Atsushi Takahashi, Yoichiro Kamatani, Yukihide Momozawa, Takeo Saito, Kenji Kondo, Ayu Shimasaki, Kohei Kawase, Takaya Sakusabe, Yoshimi Iwayama, Tomoko Toyota, Tomoyasu Wakuda, Mitsuru Kikuchi, Nobuhisa Kanahara, Hidenaga Yamamori, Yuka Yasuda, Yuichiro Watanabe, Satoshi Hoya, Branko Aleksic, Itaru Kushima, Heii Arai, Manabu Takaki, Kotaro Hattori, Hiroshi Kunugi, Yuko Okahisa, Tohru Ohnuma, Norio Ozaki, Toshiyuki Someya, Ryota Hashimoto, Takeo Yoshikawa, Michiaki Kubo, Nakao Iwata

    Schizophrenia bulletin   45 ( 4 )   824 - 834   2019.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Genome-wide association studies (GWASs) have identified >100 susceptibility loci for schizophrenia (SCZ) and demonstrated that SCZ is a polygenic disorder determined by numerous genetic variants but with small effect size. We conducted a GWAS in the Japanese (JPN) population (a) to detect novel SCZ-susceptibility genes and (b) to examine the shared genetic risk of SCZ across (East Asian [EAS] and European [EUR]) populations and/or that of trans-diseases (SCZ, bipolar disorder [BD], and major depressive disorder [MDD]) within EAS and between EAS and EUR (trans-diseases/populations). Among the discovery GWAS subjects (JPN-SCZ GWAS: 1940 SCZ cases and 7408 controls) and replication dataset (4071 SCZ cases and 54479 controls), both comprising JPN populations, 3 novel susceptibility loci for SCZ were identified: SPHKAP (Pbest = 4.1 × 10-10), SLC38A3 (Pbest = 5.7 × 10-10), and CABP1-ACADS (Pbest = 9.8 × 10-9). Subsequent meta-analysis between our samples and those of the Psychiatric GWAS Consortium (PGC; EUR samples) and another study detected 12 additional susceptibility loci. Polygenic risk score (PRS) prediction revealed a shared genetic risk of SCZ across populations (Pbest = 4.0 × 10-11) and between SCZ and BD in the JPN population (P ~ 10-40); however, a lower variance-explained was noted between JPN-SCZ GWAS and PGC-BD or MDD within/across populations. Genetic correlation analysis supported the PRS results; the genetic correlation between JPN-SCZ and PGC-SCZ was ρ = 0.58, whereas a similar/lower correlation was observed between the trans-diseases (JPN-SCZ vs JPN-BD/EAS-MDD, rg = 0.56/0.29) or trans-diseases/populations (JPN-SCZ vs PGC-BD/MDD, ρ = 0.38/0.12). In conclusion, (a) Fifteen novel loci are possible susceptibility genes for SCZ and (b) SCZ "risk" effect is shared with other psychiatric disorders even across populations.

    DOI: 10.1093/schbul/sby140

    PubMed

    researchmap

  • Rare compound heterozygous missense <i>SPATA7</i> variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control study. Reviewed International journal

    Igeta H, Watanabe Y, Morikawa R, Ikeda M, Otsuka I, Hoya S, Koizumi M, Egawa J, Hishimoto A, Iwata N, Someya T

    Neuropsychiatric disease and treatment   15   2353 - 2363   2019

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose: Whole-exome sequencing (WES) of multiplex families is a promising strategy for identifying causative variations for common diseases. To identify rare recessive risk variations for schizophrenia, we performed a WES study in a consanguineous family with affected siblings. We then performed follow-up sequencing of SPATA7 in schizophrenia-affected families. In addition, we performed a case-control study to investigate association between SPATA7 variations and schizophrenia. Patients and methods: WES was performed on two affected siblings and their unaffected parents, who were second cousins, of a multiplex schizophrenia family. Subsequently, we sequenced the coding region of SPATA7, a potential risk gene identified by the WES analysis, in 142 affected offspring from 137 families for whom parental DNA samples were available. We further tested rare recessive SPATA7 variations, identified by WES and sequencing, for associations with schizophrenia in 2,756 patients and 2,646 controls. Results: Our WES analysis identified rare compound heterozygous missense SPATA7 variations, p.Asp134Gly and p.Ile332Thr, in both affected siblings. Sequencing SPATA7 coding regions from 137 families identified no rare recessive variations in affected offspring. In the case-control study, we did not detect the rare compound heterozygous SPATA7 missense variations in patients or controls. Conclusion: Our data does not support the role of the rare compound heterozygous SPATA7 missense variations p.Asp134Gly and p.Ile332Thr in conferring a substantial risk of schizophrenia.

    DOI: 10.2147/NDT.S218773

    PubMed

    researchmap

  • Pathological alterations of chondroitin sulfate moiety in postmortem hippocampus of patients with schizophrenia. Reviewed International journal

    Yukawa T, Iwakura Y, Takei N, Saito M, Watanabe Y, Toyooka K, Igarashi M, Niizato K, Oshima K, Kunii Y, Yabe H, Matsumoto J, Wada A, Hino M, Iritani S, Niwa SI, Takeuchi R, Takahashi H, Kakita A, Someya T, Nawa H

    Psychiatry research   270   940 - 946   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Perineuronal nets comprise chondroitin sulfate moieties and their core proteins, and their neuropathological alterations have been implicated in schizophrenia. To explore the molecular mechanism of the perineuronal net impairments in schizophrenia, we measured the immunoreactivity of chondroitin sulfate moieties, major components of perineuronal nets, in three brain regions (postmortem dorsolateral prefrontal cortex, caudate nucleus, and hippocampus) of schizophrenia patients and control subjects. Immunoblotting for chondroitin 4-sulfate and chondroitin 6-sulfate moieties revealed a significant increase in intensity of a 180 kD band of chondroitin 4-sulfate immunoreactivity in the hippocampus of patients, although we detected no significant alteration in their immunoreactivities with any other molecular sizes or in other brain regions. The levels of immunoreactivity were not correlated with postmortem interval, age, or storage time. We failed to find such an increase in a similar molecular range of the chondroitin 4-sulfate immunoreactivity in the hippocampus of the rats chronically treated with haloperidol. These results suggest that the level alteration of the chondroitin 4-sulfate moiety might contribute to the perineuronal net abnormality found in patients with schizophrenia.

    DOI: 10.1016/j.psychres.2018.10.062

    PubMed

    researchmap

  • Updated meta-analysis of CMYA5 rs3828611 and rs4704591 with schizophrenia in Asian populations. Reviewed

    Hoya S, Watanabe Y, Shibuya M, Someya T

    Early intervention in psychiatry   12 ( 5 )   938 - 941   2018.10

  • Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights. Reviewed International journal

    Itaru Kushima, Branko Aleksic, Masahiro Nakatochi, Teppei Shimamura, Takashi Okada, Yota Uno, Mako Morikawa, Kanako Ishizuka, Tomoko Shiino, Hiroki Kimura, Yuko Arioka, Akira Yoshimi, Yuto Takasaki, Yanjie Yu, Yukako Nakamura, Maeri Yamamoto, Tetsuya Iidaka, Shuji Iritani, Toshiya Inada, Nanayo Ogawa, Emiko Shishido, Youta Torii, Naoko Kawano, Yutaka Omura, Toru Yoshikawa, Tokio Uchiyama, Toshimichi Yamamoto, Masashi Ikeda, Ryota Hashimoto, Hidenaga Yamamori, Yuka Yasuda, Toshiyuki Someya, Yuichiro Watanabe, Jun Egawa, Ayako Nunokawa, Masanari Itokawa, Makoto Arai, Mitsuhiro Miyashita, Akiko Kobori, Michio Suzuki, Tsutomu Takahashi, Masahide Usami, Masaki Kodaira, Kyota Watanabe, Tsukasa Sasaki, Hitoshi Kuwabara, Mamoru Tochigi, Fumichika Nishimura, Hidenori Yamasue, Yosuke Eriguchi, Seico Benner, Masaki Kojima, Walid Yassin, Toshio Munesue, Shigeru Yokoyama, Ryo Kimura, Yasuko Funabiki, Hirotaka Kosaka, Makoto Ishitobi, Tetsuro Ohmori, Shusuke Numata, Takeo Yoshikawa, Tomoko Toyota, Kazuhiro Yamakawa, Toshimitsu Suzuki, Yushi Inoue, Kentaro Nakaoka, Yu-Ichi Goto, Masumi Inagaki, Naoki Hashimoto, Ichiro Kusumi, Shuraku Son, Toshiya Murai, Tempei Ikegame, Naohiro Okada, Kiyoto Kasai, Shohko Kunimoto, Daisuke Mori, Nakao Iwata, Norio Ozaki

    Cell reports   24 ( 11 )   2838 - 2856   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Compelling evidence in Caucasian populations suggests a role for copy-number variations (CNVs) in autism spectrum disorder (ASD) and schizophrenia (SCZ). We analyzed 1,108 ASD cases, 2,458 SCZ cases, and 2,095 controls in a Japanese population and confirmed an increased burden of rare exonic CNVs in both disorders. Clinically significant (or pathogenic) CNVs, including those at 29 loci common to both disorders, were found in about 8% of ASD and SCZ cases, which was significantly higher than in controls. Phenotypic analysis revealed an association between clinically significant CNVs and intellectual disability. Gene set analysis showed significant overlap of biological pathways in both disorders including oxidative stress response, lipid metabolism/modification, and genomic integrity. Finally, based on bioinformatics analysis, we identified multiple disease-relevant genes in eight well-known ASD/SCZ-associated CNV loci (e.g., 22q11.2, 3q29). Our findings suggest an etiological overlap of ASD and SCZ and provide biological insights into these disorders.

    DOI: 10.1016/j.celrep.2018.08.022

    PubMed

    researchmap

  • Longer telomeres in elderly schizophrenia are associated with long-term hospitalization in the Japanese population. Reviewed International journal

    Yuan Zhang, Akitoyo Hishimoto, Ikuo Otsuka, Yuichiro Watanabe, Shusuke Numata, Hidenaga Yamamori, Shuken Boku, Tadasu Horai, Toshiyuki Someya, Tetsuro Ohmori, Ryota Hashimoto, Ichiro Sora

    Journal of psychiatric research   103   161 - 166   2018.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Several previous studies have investigated an association between leukocyte telomere length (LTL) and schizophrenia (SCZ). However, results have been largely inconsistent, partially due to the relatively small sample sizes in each study and heterogeneity caused by various uncontrolled confounders (e.g., duration of illness or hospitalization, lifetime antipsychotic dose, and LTL assay methods). Here, we investigate the association of LTL with SCZ with the quantitative polymerase chain reaction method in independent cohorts consisting of 1241 patients with SCZ and 1042 controls (the largest independent sample in this field). Furthermore, we examined whether duration of hospitalization and lifetime antipsychotic dose had an effect on LTL in SCZ. In all samples, we observed significantly longer LTL in patients with SCZ relative to controls. In subgroup analyses, we observed that longer telomeres in SCZ were only visible in elderly patients and not in patients under 50 years old. Moreover, significantly longer LTL in elderly patients with SCZ was only specific to those with long-term hospitalization, but not outpatients or those with short-term hospitalization. This may be because the former received more appropriate lifestyle management. Meanwhile, lifetime antipsychotic dose had no effect on LTL. Our findings suggest that consideration of the effect of age and duration of hospitalization on LTL may improve our understanding of controversial results obtained in previous studies of telomeres in SCZ.

    DOI: 10.1016/j.jpsychires.2018.05.014

    PubMed

    researchmap

  • Increased serum levels and promoter polymorphisms of macrophage migration inhibitory factor in schizophrenia. Reviewed International journal

    Satoshi Okazaki, Akitoyo Hishimoto, Ikuo Otsuka, Yuichiro Watanabe, Shusuke Numata, Shuken Boku, Naofumi Shimmyo, Makoto Kinoshita, Emiko Inoue, Tetsuro Ohmori, Toshiyuki Someya, Ichiro Sora

    Progress in neuro-psychopharmacology & biological psychiatry   83   33 - 41   2018.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Numerous studies have suggested that an immune system imbalance plays an important role in schizophrenia. Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine. It plays multiple roles in various biological processes, including inflammation and neurogenesis. Furthermore, several exhaustive serum proteomic profiling studies have identified MIF as a potential biomarker of schizophrenia. Here, we investigate MIF protein levels in serum and postmortem prefrontal cortex in patients with schizophrenia and controls. Moreover, we investigate the association of two functional polymorphisms in the MIF gene promoter region (MIF-794CATT5-8 microsatellite and MIF-173G/C single-nucleotide polymorphism [SNP]) with schizophrenia. METHODS: We measured serum MIF levels with an enzyme-linked immunosorbent assay (ELISA) (51 patients vs. 86 controls) and postmortem brain MIF levels with a western blotting assay (18 patients vs. 22 controls). Subsequently, we genotyped the MIF-794CATT5-8 microsatellite with a fluorescence-based fragment assay and the MIF-173G/C SNP with a TaqMan SNP genotyping assay (1483 patients vs. 1454 controls). RESULTS: Serum MIF levels were significantly higher in patients with schizophrenia than in controls (p=0.00118), and were positively correlated with antipsychotic dose (Spearman's r=0.222, p=0.0402). In addition, an earlier age of onset was observed in patients with a high serum MIF level (≥40ng/mL) than those with a low serum MIF level (<40ng/mL) (p=0.0392). However, postmortem brain MIF levels did not differ between patients with schizophrenia and controls. The association study revealed that the CATT6-G haplotype was nominally significantly associated with schizophrenia (p=0.0338), and that the CATT6 allele and CATT6-G haplotype were significantly associated with female adolescent-onset schizophrenia (AsOS) (corrected p=0.0222 and p=0.0147, respectively). CONCLUSIONS: These results suggest that serum MIF level is a potential pharmacodynamic and/or monitoring marker of schizophrenia, and is related to a novel antipsychotic effect beyond dopamine antagonism. Furthermore, the MIF gene polymorphisms are associated with the risk for schizophrenia especially in adolescent females, and are potential stratification markers of schizophrenia. Further studies of MIF are warranted to elucidate the pathophysiology of schizophrenia and the effects of antipsychotics.

    DOI: 10.1016/j.pnpbp.2018.01.001

    PubMed

    researchmap

  • Rare PDCD11 variations are not associated with risk of schizophrenia in Japan Reviewed

    Satoshi Hoya, Yuichiro Watanabe, Akitoyo Hishimoto, Ayako Nunokawa, Naoshi Kaneko, Tatsuyuki Muratake, Naofumi Shinmyo, Ikuo Otsuka, Shujiro Okuda, Emiko Inoue, Hirofumi Igeta, Masako Shibuya, Jun Egawa, Naoki Orime, Ichiro Sora, Toshiyuki Someya

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   71 ( 11 )   780 - 788   2017.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/pcn.12564

    Web of Science

    PubMed

    researchmap

  • Rare FBXO18 variations and risk of schizophrenia: Whole-exome sequencing in two parent-affected offspring trios followed by resequencing and case-control studies Reviewed

    Satoshi Hoya, Yuichiro Watanabe, Akitoyo Hishimoto, Ayako Nunokawa, Emiko Inoue, Hirofumi Igeta, Ikuo Otsuka, Masako Shibuya, Jun Egawa, Ichiro Sora, Toshiyuki Someya

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   71 ( 8 )   562 - 568   2017.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/pcn.12526

    Web of Science

    PubMed

    researchmap

  • High-resolution copy number variation analysis of schizophrenia in Japan Reviewed

    I. Kushima, B. Aleksic, M. Nakatochi, T. Shimamura, T. Shiino, A. Yoshimi, H. Kimura, Y. Takasaki, C. Wang, J. Xing, K. Ishizuka, T. Oya-Ito, Y. Nakamura, Y. Arioka, T. Maeda, M. Yamamoto, M. Yoshida, H. Noma, S. Hamada, M. Morikawa, Y. Uno, T. Okada, T. Iidaka, S. Iritani, T. Yamamoto, M. Miyashita, A. Kobori, M. Arai, M. Itokawa, M-C Cheng, Y-A Chuang, C-H Chen, M. Suzuki, T. Takahashi, R. Hashimoto, H. Yamamori, Y. Yasuda, Y. Watanabe, A. Nunokawa, T. Someya, M. Ikeda, T. Toyota, T. Yoshikawa, S. Numata, T. Ohmori, S. Kunimoto, D. Mori, N. Iwata, N. Ozaki

    MOLECULAR PSYCHIATRY   22 ( 3 )   430 - 440   2017.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/mp.2016.88

    Web of Science

    PubMed

    researchmap

  • 自閉スペクトラム症多発罹患家系の全エクソームシークエンスおよびフォローアップ研究

    井上 絵美子, 渡部 雄一郎, 江川 純, 杉本 篤言, 布川 綾子, 澁谷 雅子, 井桁 裕文, 染矢 俊幸

    精神神経学雑誌   119 ( 1 )   3 - 8   2017.1

     More details

    Language:Japanese   Publisher:(公社)日本精神神経学会  

    CiNii Article

    researchmap

  • Rare UNC13B variations and risk of schizophrenia: Whole-exome sequencing in a multiplex family and follow-up resequencing and a case-control study Reviewed

    Jun Egawa, Satoshi Hoya, Yuichiro Watanabe, Ayako Nunokawa, Masako Shibuya, Masashi Ikeda, Emiko Inoue, Shujiro Okuda, Kenji Kondo, Takeo Saito, Naoshi Kaneko, Tatsuyuki Muratake, Hirofumi Igeta, Nakao Iwata, Toshiyuki Someya

    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS   171 ( 6 )   797 - 805   2016.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/ajmg.b.32444

    Web of Science

    PubMed

    researchmap

  • Rare truncating variations and risk of schizophrenia: Whole-exome sequencing in three families with affected siblings and a three-stage follow-up study in a Japanese population Reviewed

    Yuichiro Watanabe, Ayako Nunokawa, Masako Shibuya, Masashi Ikeda, Akitoyo Hishimoto, Kenji Kondo, Jun Egawa, Naoshi Kaneko, Tatsuyuki Muratake, Takeo Saito, Satoshi Okazaki, Ayu Shimasaki, Hirofumi Igeta, Emiko Inoue, Satoshi Hoya, Takuro Sugai, Ichiro Sora, Nakao Iwata, Toshiyuki Someya

    PSYCHIATRY RESEARCH   235   13 - 18   2016.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.psychres.2015.12.011

    Web of Science

    PubMed

    researchmap

  • Resequencing and Association Analysis of CLN8 with Autism Spectrum Disorder in a Japanese Population Reviewed

    Emiko Inoue, Yuichiro Watanabe, Jingrui Xing, Itaru Kushima, Jun Egawa, Shujiro Okuda, Satoshi Hoya, Takashi Okada, Yota Uno, Kanako Ishizuka, Atsunori Sugimoto, Hirofumi Igeta, Ayako Nunokawa, Toshiro Sugiyama, Norio Ozaki, Toshiyuki Someya

    PLOS ONE   10 ( 12 )   e0144624   2015.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1371/journal.pone.0144624

    Web of Science

    PubMed

    researchmap

  • Association analysis of the HLA-DRB1*01 and HLA-DRB1*04 with schizophrenia by tag SNP genotyping in the Japanese population Reviewed

    Woraphat Ratta-Apha, Shuken Boku, Kentaro Mouri, Satoshi Okazaki, Ikuo Otsuka, Ichiro Sora, Akitoyo Hishimoto, Yuichiro Watanabe, Ayako Nunokawa, Toshiyuki Someya, Osamu Shirakawa

    PSYCHIATRY RESEARCH   229 ( 1-2 )   627 - 628   2015.9

  • Whole-exome sequencing in a family with a monozygotic twin pair concordant for autism spectrum disorder and a follow-up study Reviewed

    Jun Egawa, Yuichiro Watanabe, Atsunori Sugimoto, Ayako Nunokawa, Masako Shibuya, Hirofumi Igeta, Emiko Inoue, Satoshi Hoya, Naoki Orime, Taketsugu Hayashi, Toshiro Sugiyama, Toshiyuki Someya

    PSYCHIATRY RESEARCH   229 ( 1-2 )   599 - 601   2015.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.psychres.2015.07.018

    Web of Science

    PubMed

    researchmap

  • Rare heterozygous truncating variations and risk of autism spectrum disorder: Whole-exome sequencing of a multiplex family and follow-up study in a Japanese population Reviewed

    Emiko Inoue, Yuichiro Watanabe, Jun Egawa, Atsunori Sugimoto, Ayako Nunokawa, Masako Shibuya, Hirofumi Igeta, Toshiyuki Someya

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   69 ( 8 )   472 - 476   2015.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/pcn.12274

    Web of Science

    PubMed

    researchmap

  • Assessment of copy number variations in the brain genome of schizophrenia patients Reviewed

    Miwako Sakai, Yuichiro Watanabe, Toshiyuki Someya, Kazuaki Araki, Masako Shibuya, Kazuhiro Niizato, Kenichi Oshima, Yasuto Kunii, Hirooki Yabe, Junya Matsumoto, Akira Wada, Mizuki Hino, Takeshi Hashimoto, Akitoyo Hishimoto, Noboru Kitamura, Shuji Iritani, Osamu Shirakawa, Kiyoshi Maeda, Akinori Miyashita, Shin-ichi Niwa, Hitoshi Takahashi, Akiyoshi Kakita, Ryozo Kuwano, Hiroyuki Nawa

    MOLECULAR CYTOGENETICS   8   46   2015.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s13039-015-0144-5

    Web of Science

    PubMed

    researchmap

  • 高校生に対するシミュレータ実習を含む体験講座の効果

    伊藤 正洋, 鈴木 利哉, 渡部 雄一郎, 赤石 隆夫, 井口 清太郎, 土田 正則, 佐藤 昇, 竹林 浩秀, 牛木 辰男

    日本シミュレーション医療教育学会雑誌   3   17 - 20   2015.6

     More details

    Language:Japanese   Publisher:日本シミュレーション医療教育学会  

    CiNii Article

    researchmap

  • DRD2 Ser311Cys Polymorphism and Risk of Schizophrenia Reviewed

    Yuichiro Watanabe, Masako Shibuya, Toshiyuki Someya

    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS   168 ( 3 )   224 - 228   2015.4

     More details

  • Resequencing and association analysis of OXTR with autism spectrum disorder in a Japanese population Reviewed

    Jun Egawa, Yuichiro Watanabe, Masako Shibuya, Taro Endo, Atsunori Sugimoto, Hirofumi Igeta, Ayako Nunokawa, Emiko Inoue, Toshiyuki Someya

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   69 ( 3 )   131 - 135   2015.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/pcn.12205

    Web of Science

    PubMed

    researchmap

  • Novel Rare Missense Variations and Risk of Autism Spectrum Disorder: Whole-Exome Sequencing in Two Families with Affected Siblings and a Two-Stage Follow-Up Study in a Japanese Population Reviewed

    Jun Egawa, Yuichiro Watanabe, Chenyao Wang, Emiko Inoue, Atsunori Sugimoto, Toshiro Sugiyama, Hirofumi Igeta, Ayako Nunokawa, Masako Shibuya, Itaru Kushima, Naoki Orime, Taketsugu Hayashi, Takashi Okada, Yota Uno, Norio Ozaki, Toshiyuki Someya

    PLOS ONE   10 ( 3 )   e0119413   2015.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1371/journal.pone.0119413

    Web of Science

    PubMed

    researchmap

  • Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population. Reviewed International journal

    Ikuo Otsuka, Yuichiro Watanabe, Akitoyo Hishimoto, Shuken Boku, Kentaro Mouri, Kyoichi Shiroiwa, Satoshi Okazaki, Ayako Nunokawa, Osamu Shirakawa, Toshiyuki Someya, Ichiro Sora

    Neuropsychiatric disease and treatment   11   1381 - 93   2015

     More details

    Language:English  

    BACKGROUND: Cadherin13 (CDH13) is a glycosylphosphatidylinositol-anchored cell adhesion molecule that plays a crucial role in morphogenesis and the maintenance of neuronal circuitry. CDH13 has been implicated in the susceptibility to a variety of psychiatric diseases. A recent genome-wide association study using Danish samples showed, for the first time, the involvement of a single nucleotide polymorphism (SNP) of CDH13 (intronic SNP rs8057927) in schizophrenia. Here, we investigated the association between other SNPs of CDH13 and schizophrenia and tried to replicate the association for the SNP of rs8057927, in the Japanese population. METHODS: Using TaqMan(®) SNP genotyping assays, five tag SNPs (rs12925602, rs7193788, rs736719, rs6565051, and rs7204454) in the promoter region of CDH13 were examined for their association with schizophrenia in two independent samples. The first sample comprised 665 patients and 760 controls, and the second sample comprised 677 patients and 667 controls. One tag SNP for rs8057927 was also examined for the association with schizophrenia in the first sample set. RESULTS: A GACAG haplotype of the five SNPs in the promoter region of CDH13 was significantly associated with schizophrenia in the first sample set (P=0.016 and corrected P=0.098). A combined analysis of the GACAG haplotype with the second sample set enhanced the significance (P=0.0026 and corrected P=0.021). We found no association between rs8057927 and schizophrenia in the first sample set. CONCLUSION: Our results suggest that CDH13 may contribute to the genetic risk of schizophrenia. Further replication on the association of CDH13 with schizophrenia and functional studies are required to confirm the current findings.

    DOI: 10.2147/NDT.S84736

    PubMed

    researchmap

  • 統合失調症の分子病態解明を目指して

    渡部 雄一郎

    新潟県医師会報   ( 776 )   2 - 7   2014.11

     More details

    Language:Japanese   Publisher:新潟県医師会  

    J-GLOBAL

    researchmap

  • Association analysis of putative cis-acting polymorphisms of interleukin-19 gene with schizophrenia Reviewed

    Satoshi Okazaki, Yuichiro Watanabe, Akitoyo Hishimoto, Toru Sasada, Kentaro Mouri, Kyoichi Shiroiwa, Noriomi Eguchi, Woraphat Ratta-Apha, Ikuo Otsuka, Ayako Nunokawa, Naoshi Kaneko, Masako Shibuya, Toshiyuki Someya, Osamu Shirakawa, Ichiro Sora

    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY   50   151 - 156   2014.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pnpbp.2013.12.006

    Web of Science

    PubMed

    researchmap

  • A rare MIR138-2 gene variation is associated with schizophrenia in a Japanese population Reviewed

    Yuichiro Watanabe, Masako Shibuya, Ayako Nunokawa, Naoshi Kaneko, Hirofumi Igeta, Jun Egawa, Toshiyuki Someya, Akitoyo Hishimoto, Kentaro Mouri, Ichiro Sora

    PSYCHIATRY RESEARCH   215 ( 3 )   801 - 802   2014.3

  • The cardiomyopathy-associated 5 (CMYA5) gene and risk of schizophrenia: Meta-analysis of rs3828611 and rs4704591 in East Asian populations Reviewed

    Yuichiro Watanabe, Masako Shibuya, Toshiyuki Someya

    Asian Journal of Psychiatry   7 ( 1 )   95 - 96   2014.2

     More details

  • Molecular Pathology of Schizophrenia

    Watanabe Yuichiro

    新潟医学会雑誌   128 ( 1 )   7 - 12   2014.1

     More details

    Language:Japanese   Publisher:新潟医学会  

    統合失調症は複数の遺伝要因と環境要因が相互に影響し合って発症する複雑な脳疾患であると考えられている. 統合失調症の分子病態はいまだ明らかでないが, 筆者らはその一端を解明しつつある. 統合失調症のサイトカイン仮説に基づいて, 統合失調症患者の死後脳や末梢血におけるサイトカイン発現異常を明らかにするとともに, 高い妥当性を有する統合失調症の動物モデルとして新生仔期サイトカイン投与動物を作成した. また, ゲノム解析により疾患感受性座位を同定し, ごく一部ではあるが遺伝要因を明らかにした. さらに, 統合失調症の血液検査キットの開発を目指して, 末梢血トランスクリプトーム解析に基づく診断分類予測モデルを構築し, このモデルにより高い感度・特異度をもって患者群と対照群を判別できることを示した. 統合失調症の分子病態を完全に解明し, 妥当性の高い診断法や根治的な治療法の開発につなげるために, 今後も研究を進めていくことが必要である.

    CiNii Article

    CiNii Books

    J-GLOBAL

    researchmap

  • Interleukin 1 beta gene and risk of schizophrenia: detailed case-control and family-based studies and an updated meta-analysis Reviewed

    Masako Shibuya, Yuichiro Watanabe, Ayako Nunokawa, Jun Egawa, Naoshi Kaneko, Hirofumi Igeta, Toshiyuki Someya

    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL   29 ( 1 )   31 - 37   2014.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/hup.2365

    Web of Science

    PubMed

    researchmap

  • Possible association between the oxytocin receptor gene and N-acetylaspartate of the right medial temporal lobe in autism spectrum disorders Reviewed

    Jun Egawa, Yuichiro Watanabe, Taro Endo, Hideaki Kitamura, Toshiyuki Someya

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   68 ( 1 )   83 - 83   2014.1

     More details

  • An Evaluation of Association between a Novel Hippocampal Biology Related SNP (rs7294919) and Schizophrenia Reviewed

    Jiewei Liu, Shusuke Numata, Masashi Ikeda, Yuichiro Watanabe, Xue-bin Zheng, Xiongjian Luo, Makoto Kinoshita, Ayako Nunokawa, Toshiyuki Someya, Tetsuro Ohmori, Jin-xin Bei, Siow-Ann Chong, Jimmy Lee, Zhiqiang Li, Jianjun Liu, Nakao Iwata, Yongyong Shi, Ming Li, Bing Su

    PLOS ONE   8 ( 11 )   e80696   2013.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1371/journal.pone.0080696

    Web of Science

    PubMed

    researchmap

  • Replication in a Japanese population that a MIR30E gene variation is associated with schizophrenia. Reviewed International journal

    Yuichiro Watanabe, Yoshimi Iijima, Jun Egawa, Ayako Nunokawa, Naoshi Kaneko, Tadao Arinami, Hiroshi Ujike, Toshiya Inada, Nakao Iwata, Hiroshi Kunugi, Masanari Itokawa, Tsukasa Sasaki, Norio Ozaki, Ryota Hashimoto, Masako Shibuya, Hirofumi Igeta, Toshiyuki Someya

    Schizophrenia research   150 ( 2-3 )   596 - 7   2013.11

     More details

  • Association of rs2129575 in the tryptophan hydroxylase 2 gene with clinical phenotypes of autism spectrum disorders Reviewed

    Jun Egawa, Yuichiro Watanabe, Taro Endo, Toshiyuki Someya

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   67 ( 6 )   457 - 458   2013.9

     More details

  • An association analysis of the cardiomyopathy-associated 5 (CMYA5) gene with schizophrenia in a Japanese population Reviewed

    Masaomi Furukawa, Mamoru Tochigi, Takeshi Otowa, Tadao Arinami, Toshiya Inada, Hiroshi Ujike, Yuichiro Watanabe, Nakao Iwata, Masanari Itokawa, Hiroshi Kunugi, Ryota Hashimoto, Norio Ozaki, Chihiro Kakiuchi, Kiyoto Kasai, Tsukasa Sasaki

    PSYCHIATRIC GENETICS   23 ( 4 )   179 - 180   2013.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/YPG.0b013e328360c8be

    Web of Science

    PubMed

    researchmap

  • Stigma toward schizophrenia among parents of high school students. Reviewed International journal

    Yoshii H, Watanabe Y, Mazumder AH, Kitamura H, Akazawa K

    Global journal of health science   5 ( 6 )   46 - 53   2013.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Stigma toward schizophrenia is an important area of research as it is frequently a barrier to early intervention. This study attempted to identify factors underlying stigma in Japan. Because even adolescents can develop schizophrenia, 357 Japanese parents of high school students were enrolled. All parents lived outside the areas affected by the Tohoku earthquake that occurred on March 11, 2011 (ie, parts of Iwate, Miyagi, and Fukushima prefectures). Factor analysis using the Link Devaluation-Discrimination Measure identified two factors: comparison with an able-bodied person and non-comparison with an able-bodied person. Regression analysis revealed that family structure had independent effects on factor 2 (p <0.05), and ANOVA showed that education had independent effects on factor 2 (p<0.05). These results suggest that education programs that seek to counteract stigma should target curricula in high schools and vocational schools.

    DOI: 10.5539/gjhs.v5n6p46

    PubMed

    researchmap

  • Association between OXTR and clinical phenotypes of autism spectrum disorders Reviewed

    Jun Egawa, Yuichiro Watanabe, Taro Endo, Ryu Tamura, Toshiyuki Someya, Yuichiro Watanabe, Naio Masuzawa

    PSYCHIATRY RESEARCH   208 ( 1 )   99 - 100   2013.6

  • Genetic evidence for association between NOTCH4 and schizophrenia supported by a GWAS follow-up study in a Japanese population Reviewed

    M. Ikeda, B. Aleksic, K. Yamada, Y. Iwayama-Shigeno, K. Matsuo, S. Numata, Y. Watanabe, T. Ohnuma, T. Kaneko, Y. Fukuo, T. Okochi, T. Toyota, E. Hattori, S. Shimodera, M. Itakura, A. Nunokawa, N. Shibata, H. Tanaka, H. Yoneda, H. Arai, T. Someya, T. Ohmori, T. Yoshikawa, N. Ozaki, N. Iwata

    MOLECULAR PSYCHIATRY   18 ( 6 )   636 - 638   2013.6

     More details

  • Genome-wide association study of schizophrenia using microsatellite markers in the Japanese population Reviewed

    Hiroki Shibata, Ken Yamamoto, Zhu Sun, Akira Oka, Hidetoshi Inoko, Tadao Arinami, Toshiya Inada, Hiroshi Ujike, Masanari Itokawa, Mamoru Tochigi, Yuichiro Watanabe, Toshiyuki Someya, Hiroshi Kunugi, Tatsuyo Suzuki, Nakao Iwata, Norio Ozaki, Yasuyuki Fukumaki

    PSYCHIATRIC GENETICS   23 ( 3 )   117 - 123   2013.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/YPG.0b013e32835fe4f1

    Web of Science

    PubMed

    researchmap

  • Resequencing and association analysis of MIR137 with schizophrenia in a Japanese population Reviewed

    Jun Egawa, Ayako Nunokawa, Masako Shibuya, Yuichiro Watanabe, Naoshi Kaneko, Hirofumi Igeta, Toshiyuki Someya

    Psychiatry and Clinical Neurosciences   67 ( 4 )   277 - 279   2013.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/pcn.12047

    Scopus

    PubMed

    researchmap

  • Association of the BDNFC270T polymorphism with schizophrenia: Updated meta-analysis Reviewed

    Yuichiro Watanabe, Ayako Nunokawa, Toshiyuki Someya

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   67 ( 2 )   123 - 125   2013.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/pcn.12018

    Web of Science

    PubMed

    researchmap

  • A missense mutation in the ITGA8 gene, a cell adhesion molecule gene, is associated with schizophrenia in Japanese female patients Reviewed

    Irwan Supriyanto, Yuichiro Watanabe, Kentaro Mouri, Kyoichi Shiroiwa, Woraphat Ratta-Apha, Masakuni Yoshida, Genki Tamiya, Toru Sasada, Noriomi Eguchi, Kenji Okazaki, Osamu Shirakawa, Toshiyuki Someya, Akitoyo Hishimoto

    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY   40   347 - 352   2013.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pnpbp.2012.11.002

    Web of Science

    PubMed

    researchmap

  • Pharmacogenomics in Psychiatric Disorders Reviewed

    Y.W. Francis Lam, Naoki Fukui, Takuro Sugai, Junzo Watanabe, Yuichiro Watanabe, Yutato Suzuki, Toshiyuki Someya

    Pharmacogenomics   191 - 223   2013

     More details

    Language:English   Publishing type:Part of collection (book)   Publisher:Elsevier Inc.  

    DOI: 10.1016/B978-0-12-391918-2.00006-8

    Scopus

    researchmap

  • Oxytocin receptor (OXTR) gene and risk of schizophrenia: Case-control and family-based analyses and meta-analysis in a Japanese population Reviewed

    Yuichiro Watanabe, Naoshi Kaneko, Ayako Nunokawa, Masako Shibuya, Jun Egawa, Toshiyuki Someya

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   66 ( 7 )   622 - 622   2012.12

  • Supportive evidence for the association between the Gln2Pro polymorphism in the SIGMAR1 gene and schizophrenia in the Japanese population: A case-control study and an updated meta-analysis Reviewed

    Yuichiro Watanabe, Ayako Nunokawa, Naoshi Kaneko, Masako Shibuya, Jun Egawa, Toshiyuki Someya

    SCHIZOPHRENIA RESEARCH   141 ( 2-3 )   279 - 280   2012.11

  • 薬物治療の根拠と理論 薬物治療と生物学的・薬理学的理解とのクロストーク

    渡部 雄一郎, 染矢 俊幸

    臨床精神薬理   15 ( 8 )   1267 - 1275   2012.8

     More details

    Language:Japanese   Publisher:(株)星和書店  

    J-GLOBAL

    researchmap

  • Social Distance toward schizophrenia among parents of adolescents Reviewed

    Yoshii H, Watanabe Y, Kitamura H, Ling Y, Akazawa K

    Health   4 ( 7 )   386 - 391   2012.7

     More details

    Language:English   Publisher:Scientific Research Publishing  

    DOI: 10.4236/health.2012.47061

    CiNii Article

    researchmap

  • Factors associated with an absence of effect of an education program for improving knowledge of schizophrenia. Reviewed

    Yoshii H, Watanabe Y, Kitamura H, Sakai Y, Akazawa K

    Global journal of health science   4 ( 4 )   42 - 47   2012.5

     More details

    Language:English   Publisher:Canadian Center of Science and Education  

    DOI: 10.5539/gjhs.v4n4p42

    PubMed

    CiNii Article

    researchmap

  • Exploration of a possible association between the tryptophan hydroxylase 2 (TPH2) gene and panic symptoms induced by carbon dioxide in healthy individuals Reviewed

    Ryo Abe, Yuichiro Watanabe, Akira Tachibana, Ayako Nunokawa, Masanobu Shindo, Naoya Hasegawa, Toshiyuki Someya

    PSYCHIATRY RESEARCH   197 ( 3 )   358 - 359   2012.5

  • A two-stage case-control association study between the tryptophan hydroxylase 2 (TPH2) gene and schizophrenia in a Japanese population Reviewed

    Yuichiro Watanabe, Jun Egawa, Yoshimi Iijima, Ayako Nunokawa, Naoshi Kaneko, Masako Shibuya, Tadao Arinami, Hiroshi Ujike, Toshiya Inada, Nakao Iwata, Mamoru Tochigi, Hiroshi Kunugi, Masanari Itokawa, Norio Ozaki, Ryota Hashimoto, Toshiyuki Someya

    SCHIZOPHRENIA RESEARCH   137 ( 1-3 )   264 - 266   2012.5

  • A detailed association analysis between the tryptophan hydroxylase 2 (TPH2) gene and autism spectrum disorders in a Japanese population Reviewed

    Jun Egawa, Yuichiro Watanabe, Ayako Nunokawa, Taro Endo, Naoshi Kaneko, Ryu Tamura, Toshiro Sugiyama, Toshiyuki Someya

    PSYCHIATRY RESEARCH   196 ( 2-3 )   320 - 322   2012.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.psychres.2011.09.001

    Web of Science

    PubMed

    researchmap

  • Association of SNPs linked to increased expression of SLC1A1 with schizophrenia. Reviewed International journal

    Yasue Horiuchi, Syuhei Iida, Minori Koga, Hiroki Ishiguro, Yoshimi Iijima, Toshiya Inada, Yuichiro Watanabe, Toshiyuki Someya, Hiroshi Ujike, Nakao Iwata, Norio Ozaki, Hiroshi Kunugi, Mamoru Tochigi, Masanari Itokawa, Makoto Arai, Kazuhiro Niizato, Shuji Iritani, Akiyoshi Kakita, Hitoshi Takahashi, Hiroyuki Nawa, Tadao Arinami

    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics   159B ( 1 )   30 - 7   2012.1

     More details

    Language:English  

    Glutamate is one of the key molecules involved in signal transduction in the brain, and dysfunction of glutamate signaling could be linked to schizophrenia. The SLC1A1 gene located at 9p24 encodes the glutamate transporter EAAT3/EAAC1. To investigate the association between the SLC1A1 gene and schizophrenia in the Japanese population, we genotyped 19 tagging single nucleotide polymorphisms (tagSNPs) in the SLC1A1 gene in 576 unrelated individuals with schizophrenia and 576 control subjects followed by replication in an independent case-control study of 1,344 individuals with schizophrenia and 1,344 control subjects. In addition, we determined the boundaries of the copy number variation (CNV) region in the first intron (Database of Genomic Variants, chr9:4516796-4520549) and directly genotyped the CNV because of significant deviation from the Hardy-Weinberg equilibrium. The CNV was not associated with schizophrenia. Four SNPs showed a possible association with schizophrenia in the screening subjects and the associations were replicated in the same direction (nominal allelic P < 0.05), and, among them, an association with rs7022369 was replicated even after Bonferroni correction (allelic nominal P = 5 × 10(-5) , allelic corrected P = 2.5 × 10(-4) , allelic odds ratio, 1.30; 95% CI: 1.14-1.47 in the combined subjects). Expression analysis quantified by the real-time quantitative polymerase chain reaction in the postmortem prefrontal cortex of 43 Japanese individuals with schizophrenia and 11 Japanese control subjects revealed increased SLC1A1 expression levels in individuals homozygous for the rs7022369 risk allele (P = 0.003). Our findings suggest the involvement of SLC1A1 in the pathogenesis of schizophrenia.

    DOI: 10.1002/ajmg.b.31249

    PubMed

    researchmap

  • Effect of an education program on improving help-seeking among parents of junior and senior high school students in Japan. Reviewed

    Yoshii H, Watanabe Y, Kitamura H, Nan Z, Akazawa K

    Global journal of health science   4 ( 1 )   33 - 41   2011.12

     More details

    Language:English   Publisher:Canadian Center of Science and Education  

    DOI: 10.5539/gjhs.v4n1p33

    PubMed

    CiNii Article

    researchmap

  • Positive Association of Phencyclidine-Responsive Genes, PDE4A and PLAT, With Schizophrenia Reviewed

    Xiangdong Deng, Hiromi Takaki, Lixiang Wang, Tosihide Kuroki, Tatsuo Nakahara, Kijiro Hashimoto, Hideaki Ninomiya, Tadao Arinami, Toshiya Inada, Hiroshi Ujike, Masanari Itokawa, Mamoru Tochigi, Yuichiro Watanabe, Toshiyuki Someya, Hiroshi Kunugi, Nakao Iwata, Norio Ozaki, Hiroki Shibata, Yasuyuki Fukumaki

    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS   156B ( 7 )   850 - 858   2011.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/ajmg.b.31233

    Web of Science

    PubMed

    researchmap

  • 統合失調症とマイクロRNA (特集 精神疾患とマイクロRNA)

    渡部 雄一郎, 武井 延之, 那波 宏之

    分子精神医学   11 ( 3 )   179 - 184   2011.7

     More details

    Language:Japanese   Publisher:先端医学社  

    CiNii Article

    CiNii Books

    researchmap

  • Functional Polymorphism in the GPR55 Gene is Associated With Anorexia Nervosa Reviewed

    Hiroki Ishiguro, Emmanuel S. Onaivi, Yasue Horiuchi, Keiko Imai, Gen Komaki, Toshio Ishikawa, Mari Suzuki, Yuichiro Watanabe, Tetsuya Ando, Susumu Higuchi, Tadao Arinami

    SYNAPSE   65 ( 2 )   103 - 108   2011.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/syn.20821

    Web of Science

    PubMed

    researchmap

  • Stigma toward schizophrenia among parents of junior and senior high school students in Japan Reviewed

    Hatsumi Yoshii, Yuichiro Watanabe, Hideaki Kitamura, Zhang Nan, Kouhei Akazawa

    BMC Research Notes   4   558   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/1756-0500-4-558

    Scopus

    PubMed

    researchmap

  • Reduced thalamus volume in non-right-handed male patients with autism spectrum disorders Reviewed

    Jun Egawa, Yuichiro Watanabe, Hideaki Kitamura, Taro Endo, Ryu Tamura, Naoya Hasegawa, Toshiyuki Someya

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   65 ( 4 )   395 - 395   2011

  • A case-control study and meta-analysis of association between a common copy number variation of the glutathione S-transferase mu I (GSTM1) gene and schizophrenia Reviewed

    Yuichiro Watanabe, Ayako Nunokawa, Naoshi Kaneko, Toshiyuki Someya

    SCHIZOPHRENIA RESEARCH   124 ( 1-3 )   236 - 237   2010.12

  • An association study between the dymeclin gene and schizophrenia in the Japanese population Reviewed

    Saori Yazaki, Minori Koga, Hiroki Ishiguro, Toshiya Inada, Hiroshi Ujike, Masanari Itokawa, Takeshi Otowa, Yuichiro Watanabe, Toshiyuki Someya, Nakao Iwata, Hiroshi Kunugi, Norio Ozaki, Tadao Arinami

    JOURNAL OF HUMAN GENETICS   55 ( 9 )   631 - 634   2010.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/jhg.2010.72

    Web of Science

    PubMed

    researchmap

  • Psychiatric disorders

    渡部 雄一郎, 染矢 俊幸

    Japanese journal of clinical medicine   68 ( 0 )   402 - 405   2010.8

     More details

    Language:Japanese   Publisher:日本臨床社  

    CiNii Article

    CiNii Books

    researchmap

  • Supportive Evidence for Reduced Expression of GNB1L in Schizophrenia Reviewed

    Hiroki Ishiguro, Minori Koga, Yasue Horiuchi, Emiko Noguchi, Miyuki Morikawa, Yoshimi Suzuki, Makoto Arai, Kazuhiro Niizato, Shyuji Iritani, Masanari Itokawa, Toshiya Inada, Nakao Iwata, Norio Ozaki, Hiroshi Ujike, Hiroshi Kunugi, Tsukasa Sasaki, Makoto Takahashi, Yuichiro Watanabe, Toshiyuki Someya, Akiyoshi Kakita, Hitoshi Takahashi, Hiroyuki Nawa, Tadao Arinami

    SCHIZOPHRENIA BULLETIN   36 ( 4 )   756 - 765   2010.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1093/schbul/sbn160

    Web of Science

    PubMed

    researchmap

  • Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism Reviewed

    M. Shibuya, E. Komi, R. Wang, T. Kato, Y. Watanabe, M. Sakai, M. Ozaki, T. Someya, H. Nawa

    JOURNAL OF NEURAL TRANSMISSION   117 ( 7 )   887 - 895   2010.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00702-010-0418-3

    Web of Science

    PubMed

    researchmap

  • Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures Reviewed

    Makoto Takahashi, Hiroshi Hayashi, Yuichiro Watanabe, Kazushi Sawamura, Naoki Fukui, Junzo Watanabe, Tsuyoshi Kitajima, Yoshio Yamanouchi, Nakao Iwata, Katsuyoshi Mizukami, Takafumi Hori, Kazutaka Shimoda, Hiroshi Ujike, Norio Ozaki, Kentarou Iijima, Kazuo Takemura, Hideyuki Aoshima, Toshiyuki Someya

    SCHIZOPHRENIA RESEARCH   119 ( 1-3 )   210 - 218   2010.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.schres.2009.12.024

    Web of Science

    PubMed

    researchmap

  • Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. Reviewed

    Watanabe Yuichiro, Someya Toshiyuki, Nawa Hiroyuki

    Psychiatry Clin Neurosci   64 ( 3 )   217 - 230   2010.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/j.1440-1819.2010.02094.x

    Web of Science

    PubMed

    researchmap

  • Replication study of association between ADCYAP1 gene polymorphisms and schizophrenia Reviewed

    Minori Koga, Hiroki Ishiguro, Yasue Horiuchi, Toshiya Inada, Hiroshi Ujike, Masanari Itokawa, Takeshi Otowa, Yuichiro Watanabe, Toshiyuki Someya, Tadao Arinami

    PSYCHIATRIC GENETICS   20 ( 3 )   123 - 125   2010.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/YPG.0b013e32833a1f52

    Web of Science

    PubMed

    researchmap

  • Brain cannabinoid CB2 receptor in schizophrenia. Reviewed

    Ishiguro Hiroki, Horiuchi Yasue, Ishikawa Maya, Koga Minori, Imai Keiko, Suzuki Yoshimi, Morikawa Miyuki, Inada Toshiya, Watanabe Yuichiro, Takahashi Makoto, Someya Toshiyuki, Ujike Hiroshi, Iwata Nakao, Ozaki Norio, Onaivi Emmanuel S, Kunugi Hiroshi, Sasaki Tsukasa, Itokawa Masanari, Arai Makoto, Niizato Kazuhiro, Iritani Shyuji, Naka Izumi, Ohashi Jun, Kakita Akiyoshi, Takahashi Hitoshi, Nawa Hiroyuki, Arinami Tadao

    Biol Psychiatry   67 ( 10 )   974 - 982   2010.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.biopsych.2009.09.024

    Web of Science

    PubMed

    researchmap

  • Failure to find an association between myosin heavy chain 9, non-muscle (MYH9) and schizophrenia: A three-stage case-control association study Reviewed

    Hideki Amagane, Yuichiro Watanabe, Naoshi Kaneko, Ayako Nunokawa, Tatsuyuki Muratake, Hiroki Ishiguro, Tadao Arinami, Hiroshi Ujike, Toshiya Inada, Nakao Iwata, Hiroshi Kunugi, Tsukasa Sasaki, Ryota Hashimoto, Masanari Itokawa, Norio Ozaki, Toshiyuki Someya

    SCHIZOPHRENIA RESEARCH   118 ( 1-3 )   106 - 112   2010.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.schres.2010.01.023

    Web of Science

    PubMed

    researchmap

  • A case-control association analysis of CABIN1 with schizophrenia in a Japanese population Reviewed

    Yuichiro Watanabe, Ayako Nunokawa, Naoshi Kaneko, Toshiyuki Someya

    JOURNAL OF HUMAN GENETICS   55 ( 3 )   179 - 181   2010.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/jhg.2009.136

    Web of Science

    PubMed

    researchmap

  • Donepezil服用後にパーキンソニズムが悪化したレビー小体型認知症の1例

    常山 暢人, 渡部 雄一郎, 澤村 一司, 染矢 俊幸

    臨床精神薬理   13 ( 2 )   397 - 402   2010.2

     More details

    Language:Japanese   Publisher:(株)星和書店  

    J-GLOBAL

    researchmap

  • The dopamine D3 receptor (DRD3) gene and risk of schizophrenia: Case-control studies and an updated meta-analysis Reviewed

    Ayako Nunokawa, Yuichiro Watanabe, Naoshi Kaneko, Takuro Sugai, Saori Yazaki, Tadao Arinami, Hiroshi Ujike, Toshiya Inada, Nakao Iwata, Hiroshi Kunugi, Tsukasa Sasaki, Masanari Itokawa, Norio Ozaki, Ryota Hashimoto, Toshiyuki Someya

    SCHIZOPHRENIA RESEARCH   116 ( 1 )   61 - 67   2010.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.schres.2009.10.016

    Web of Science

    PubMed

    researchmap

  • Cytokine hypothesis of schizophrenia pathogenesis: Evidence from human studies and animal models Reviewed

    Yuichiro Watanabe, Toshiyuki Someya, Hiroyuki Nawa

    Psychiatry and Clinical Neurosciences   64 ( 3 )   217 - 230   2010

     More details

    Language:English   Publisher:Blackwell Publishing Ltd  

    DOI: 10.1111/j.1440-1819.2010.02094.x

    Scopus

    PubMed

    researchmap

  • Preliminary Genome-Wide Association Study of Bipolar Disorder in the Japanese Population Reviewed

    Eiji Hattori, Tomoko Toyota, Yuichi Ishitsuka, Yoshimi Iwayama, Kazuo Yamada, Hiroshi Ujike, Yukitaka Morita, Masafumi Kodama, Kenji Nakata, Yoshio Minabe, Kazuhiko Nakamura, Yasuhide Iwata, Nori Takei, Norio Mori, Hiroshi Naitoh, Yoshio Yamanouchi, Nakao Iwata, Norio Ozaki, Tadafumi Kato, Toru Nishikawa, Atsushi Kashiwa, Mika Suzuki, Kunihiko Shioe, Manabu Shinohara, Masami Hirano, Shinichiro Nanko, Akihisa Akahane, Mikako Ueno, Naoshi Kaneko, Yuichiro Watanabe, Toshiyuki Someya, Kenji Hashimoto, Masaomi Iyo, Masanari Itokawa, Makoto Arai, Masahiro Nankai, Toshiya Inada, Sumiko Yoshida, Hiroshi Kunugi, Michiko Nakamura, Yoshimi Iijima, Yuji Okazaki, Teruhiko Higuchi, Takeo Yoshikawa

    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS   150B ( 8 )   1110 - 1117   2009.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/ajmg.b.30941

    Web of Science

    PubMed

    researchmap

  • モデル動物を用いた中枢神経系機能性疾患の病態解析 モデル動物を用いた統合失調症病態解析

    渡部雄一郎, 那波宏之, 染矢俊幸

    脳と精神の医学   20 ( 3 )   213 - 220   2009.9

     More details

    Language:Japanese   Publisher:Japanese Society of Biological Psychiatry  

    DOI: 10.11249/jsbp.20.213

    CiNii Article

    CiNii Books

    J-GLOBAL

    researchmap

  • Schizophrenia and genomics

    渡部 雄一郎, 布川 綾子, 金子 尚史

    Japanese journal of clinical psychiatry   38 ( 8 )   1031 - 1037   2009.8

     More details

    Language:Japanese   Publisher:アークメディア  

    CiNii Article

    CiNii Books

    researchmap

  • A two-stage case-control association study of PADI2 with schizophrenia Reviewed

    Yuichiro Watanabe, Ayako Nunokawa, Naoshi Kaneko, Tadao Arinami, Hiroshi Ujike, Toshiya Inada, Nakao Iwata, Hiroshi Kunugi, Masanari Itokawa, Takeshi Otowa, Norio Ozaki, Toshiyuki Someya

    JOURNAL OF HUMAN GENETICS   54 ( 7 )   430 - 432   2009.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/jhg.2009.52

    Web of Science

    PubMed

    researchmap

  • Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia Reviewed

    Minori Koga, Hiroki Ishiguro, Saori Yazaki, Yasue Horiuchi, Makoto Arai, Kazuhiro Niizato, Shuji Iritani, Masanari Itokawa, Toshiya Inada, Nakao Iwata, Norio Ozaki, Hiroshi Ujike, Hiroshi Kunugi, Tsukasa Sasaki, Makoto Takahashi, Yuichiro Watanabe, Toshiyuki Someya, Akiyoshi Kakita, Hitoshi Takahashi, Hiroyuki Nawa, Christian Muchardt, Moshe Yaniv, Tadao Arinami

    HUMAN MOLECULAR GENETICS   18 ( 13 )   2483 - 2494   2009.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1093/hmg/ddp166

    Web of Science

    PubMed

    researchmap

  • 個別化医療 臨床的観点から 6 精神疾患とゲノム多様性

    布川綾子, 渡部雄一郎, 染矢俊幸

    治療学   43 ( 3 )   307 - 311   2009.3

     More details

  • Two-stage case-control association study of polymorphisms in rheumatoid arthritis susceptibility genes with schizophrenia Reviewed

    Yuichiro Watanabe, Ayako Nunokawa, Naoshi Kaneko, Tatsuyuki Muratake, Tadao Arinami, Hiroshi Ujike, Toshiya Inada, Nakao Iwata, Hiroshi Kunugi, Masanari Itokawa, Takeshi Otowa, Norio Ozaki, Toshiyuki Someya

    JOURNAL OF HUMAN GENETICS   54 ( 1 )   62 - 65   2009.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/jhg.2008.4

    Web of Science

    PubMed

    researchmap

  • Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia Reviewed

    Minori Koga, Hiroki Ishiguro, Saori Yazaki, Yasue Horiuchi, Makoto Arai, Kazuhiro Niizato, Shuji Iritani, Masanari Itokawa, Toshiya Inada, Nakao Iwata, Norio Ozaki, Hiroshi Ujike, Hiroshi Kunugi, Tsukasa Sasaki, Makoto Takahashi, Yuichiro Watanabe, Toshiyuki Someya, Akiyoshi Kakita, Hitoshi Takahashi, Hiroyuki Nawa, Christian Muchardt, Moshe Yaniv, Tadao Arinami

    Human Molecular Genetics   18 ( 13 )   2483 - 2494   2009

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1093/hmg/ddp166

    Web of Science

    Scopus

    PubMed

    researchmap

  • Replication study for associations between polymorphisms in the CLDN5 and DGCR2 genes in the 22q11 deletion syndrome region and schizophrenia Reviewed

    Hiroki Ishiguro, Keiko Imai, Minori Koga, Yasue Horiuchi, Toshiya Inada, Nakao Iwata, Norio Ozaki, Hiroshi Ujike, Masanari Itokawa, Hiroshi Kunugi, Tsukasa Sasaki, Yuichiro Watanabe, Toshiyuki Someya, Tadao Arinami

    PSYCHIATRIC GENETICS   18 ( 5 )   255 - 256   2008.10

  • Association study of interleukin 2 (IL2) and IL4 with schizophrenia in a Japanese population Reviewed

    Yuichiro Watanabe, Ayako Nunokawa, Masako Shibuya, Naoshi Kaneko, Hiroyuki Nawa, Toshiyuki Someya

    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE   258 ( 7 )   422 - 427   2008.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00406-008-0813-z

    Web of Science

    PubMed

    researchmap

  • Association study of interleukin 2 (IL2) and IL4 with schizophrenia in a Japanese population. Reviewed

    Watanabe Yuichiro, Nunokawa Ayako, Shibuya Masako, Kaneko Naoshi, Nawa Hiroyuki, Someya Toshiyuki

    Eur Arch Psychiatry Clin Neurosci   258 ( 7 )   422 - 427   2008.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00406-008-0813-z

    Web of Science

    PubMed

    researchmap

  • Paroxetineとnortriptylineの薬物相互作用により錐体外路症状がみられた1例

    横山 裕一, 渡部 雄一郎, 須貝 拓朗, 福井 直樹, 高橋 誠, 染矢 俊幸

    臨床精神薬理   11 ( 7 )   1343 - 1347   2008.7

     More details

    Language:Japanese   Publisher:(株)星和書店  

    J-GLOBAL

    researchmap

  • 【脳とサイトカイン 基礎と臨床】 統合失調症におけるサイトカインの機能と役割

    那波 宏之, 渡部 雄一郎, 染矢 俊幸

    Brain Medical   20 ( 2 )   167 - 172   2008.6

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

    CiNii Article

    J-GLOBAL

    researchmap

  • Large-scale case-control study of a functional polymorphism in the glutamate receptor, metabotropic 3 gene in patients with schizophrenia Reviewed

    Ayako Nunokawa, Yuichiro Watanabe, Hideaki Kitamura, Naoshi Kaneko, Tadao Arinami, Hiroshi Ujike, Toshiya Inada, Nakao Iwata, Hiroshi Kunugi, Masanari Itokawa, Norio Ozaki, Toshiyuki Someya

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   62 ( 2 )   239 - 240   2008.4

  • Association of polymorphisms in the haplotype block spanning the alternatively spliced exons of the NTNG1 gene at 1p13.3 with schizophrenia in Japanese populations Reviewed

    T. Ohtsuki, Y. Horiuchi, M. Koga, H. Ishiguro, T. Inada, N. Iwata, N. Ozaki, H. Ujike, Y. Watanabe, T. Someya, T. Arinami

    NEUROSCIENCE LETTERS   435 ( 3 )   194 - 197   2008.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.neulet.2008.02.053

    Web of Science

    PubMed

    researchmap

  • Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample Reviewed

    Masashi Ikeda, Nagahide Takahashi, Shinichi Saito, Branko Aleksic, Yuichiro Watanabe, Ayako Nunokawa, Yoshio Yamanouchi, Tsuyoshi Kitajima, Yoko Kinoshita, Taro Kishi, Kunihiro Kawashima, Ryota Hashimoto, Hiroshi Ujike, Toshiya Inada, Toshiyuki Someya, Masatoshi Takeda, Norio Ozaki, Nakao Iwata

    SCHIZOPHRENIA RESEARCH   101 ( 1-3 )   1 - 8   2008.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.schres.2008.01.010

    Web of Science

    PubMed

    researchmap

  • A polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophrenia Reviewed

    Tsuyuka Ohtsuki, Minori Koga, Hiroki Ishiguro, Yasue Horiuchi, Makoto Arai, Kazuhiro Niizato, Masanari Itokawa, Toshiya Inada, Nakao Iwata, Shyuji Iritani, Norio Ozaki, Hiroshi Kunugi, Hiroshi Ujike, Yuichiro Watanabe, Toshiuki Someya, Tadao Arinami

    SCHIZOPHRENIA RESEARCH   101 ( 1-3 )   9 - 16   2008.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.schres.2008.01.027

    Web of Science

    PubMed

    researchmap

  • Replication study and meta-analysis of the genetic association of GRM3 gene polymorphisms with schizophrenia in a large Japanese case-control population Reviewed

    Talal Albalushi, Yasue Horiuchi, Hiroki Ishiguro, Minori Koga, Toshiya Inada, Nakao Iwata, Norio Ozaki, Hiroshi Ujike, Yuichiro Watanabe, Toshiyuki Someya, Tadao Arinami

    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS   147B ( 3 )   392 - 396   2008.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/ajmg.b.30610

    Web of Science

    PubMed

    researchmap

  • The tryptophan hydroxylase 1 (TPH1) gene and risk of schizophrenia: A moderate-scale case-control study and meta-analysis Reviewed

    Yuichiro Watanabe, Ayako Nunokawa, Naoshi Kaneko, Toshiyuki Someya

    NEUROSCIENCE RESEARCH   59 ( 3 )   322 - 326   2007.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.neures.2007.08.002

    Web of Science

    PubMed

    researchmap

  • Olanzapineからaripiprazoleへの置換によりメタボリックシンドロームと高プロラクチン血症が改善した統合失調症の1例

    湯川 尊行, 渡部 雄一郎, 小泉 暢大栄, 染矢 俊幸

    臨床精神薬理   10 ( 9 )   1757 - 1762   2007.9

     More details

    Language:Japanese   Publisher:(株)星和書店  

    J-GLOBAL

    researchmap

  • No association between the tumor necrosis factor-alpha gene promoter polymorphisms and schizophrenia in a Japanese population Reviewed

    Yuichiro Watanabe, Tatsuyuki Muratake, Naoshi Kaneko, Naoki Fukui, Yasushi Nara, Toshiyuki Someya

    PSYCHIATRY RESEARCH   153 ( 1 )   1 - 6   2007.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.psychres.2006.03.009

    Web of Science

    PubMed

    researchmap

  • Meta-analysis of case-control association studies between the C270T polymorphism of the brain-derived neurotrophic factor gene and schizophrenia Reviewed

    Yuichiro Watanabe, Ayako Nunokawa, Naoshi Kaneko, Toshiyuki Someya

    SCHIZOPHRENIA RESEARCH   95 ( 1-3 )   250 - 252   2007.9

  • Lack of association between the interleukin-1 gene complex and schizophrenia in a Japanese population Reviewed

    Yuichiro Watanabe, Ayako Nunokawa, Naoshi Kaneko, Tatsuyuki Muratake, Masataka Koizumi, Toshiyuki Someya

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   61 ( 4 )   364 - 369   2007.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/j.1440-1819.2007.01671.x

    Web of Science

    PubMed

    researchmap

  • No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population Reviewed

    Ayako Nunokawa, Yulchiro Watanabe, Tatsuyuki Muratake, Naoshi Kaneko, Masataka Koizumi, Toshiyuki Sorneya

    NEUROSCIENCE RESEARCH   58 ( 3 )   291 - 296   2007.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.neures.2007.03.015

    Web of Science

    PubMed

    researchmap

  • No association between the ERBB3 gene and schizophrenia in a Japanese population Reviewed

    Yuichiro Watanabe, Naoki Fukui, Ayako Nunokawa, Tatsuyuki Muratake, Naoshi Kaneko, Hideaki Kitamura, Toshiyuki Someya

    NEUROSCIENCE RESEARCH   57 ( 4 )   574 - 578   2007.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.neures.2007.01.001

    Web of Science

    PubMed

    researchmap

  • 第2章 特定の物質の不足ないしは過剰に疾患が由来する病態 4) 非依存性医薬品 12. 抗うつ薬に由来する病態

    渡部雄一郎, 染矢俊幸

    精神科治療学   21   240 - 241   2006.10

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • Association study of a functional promoter polymorphism of the X-box binding protein 1 gene in Japanese patients with schizophrenia Reviewed

    Yuichiro Watanabe, Naoki Fukui, Tatsuyuki Muratake, Hideki Amagane, Naoshi Kaneko, Ayako Nunokawa, Toshiyuki Someya

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   60 ( 5 )   633 - 635   2006.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/j.1440-1819.2006.01570.x

    Web of Science

    PubMed

    researchmap

  • そこが知りたい薬物療法Q&A SSRIはQTc延長を惹起するか?

    熊田 智, 渡部 雄一郎, 染矢 俊幸

    臨床精神薬理   9 ( 8 )   1579 - 1580   2006.8

     More details

    Language:Japanese   Publisher:(株)星和書店  

    J-GLOBAL

    researchmap

  • Risperidoneからolanzapineへの置換により勃起障害が改善した統合失調症の1例

    横山 裕一, 渡部 雄一郎, 福井 直樹, 高橋 誠, 染矢 俊幸

    臨床精神薬理   9 ( 7 )   1425 - 1429   2006.7

     More details

    Language:Japanese   Publisher:(株)星和書店  

    J-GLOBAL

    researchmap

  • No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population Reviewed

    Y Watanabe, T Muratake, N Kaneko, A Nunokawa, T Someya

    SCHIZOPHRENIA RESEARCH   84 ( 1 )   29 - 35   2006.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.schres.2006.03.011

    Web of Science

    PubMed

    researchmap

  • 神経精神症状に対してミルナシプランの単剤投与が奏効した進行性核上性麻痺の1例

    横山 裕一, 渡部 雄一郎, 小澤 鉄太郎

    精神医学   48 ( 4 )   439 - 441   2006.4

     More details

    Language:Japanese   Publisher:医学書院  

    DOI: 10.11477/mf.1405100253

    CiNii Article

    researchmap

  • そこが知りたい薬物療法Q&A 非定型抗精神病薬は強迫症状を惹起するか?

    横山 裕一, 渡部 雄一郎, 染矢 俊幸

    臨床精神薬理   9 ( 2 )   247 - 248   2006.2

     More details

    Language:Japanese   Publisher:(株)星和書店  

    J-GLOBAL

    researchmap

  • Mania after vascular dementia in a patient with bipolar II disorder Reviewed

    Y Watanabe, T Shioiri, H Kuwabara, T Someya

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   60 ( 1 )   117 - 118   2006.2

  • Mouse schizophrenia models established with cytokines

    Tsuda Noriko, Tohmi Manavu, Watanabe Yuichiro, Someya Toshiyuki, Nawa Hiroyuki

    脳と精神の医学   17 ( 1 )   53 - 58   2006

     More details

    Language:Japanese   Publisher:日本生物学的精神医学会  

    CiNii Article

    CiNii Books

    researchmap

  • Sustained brain-derived neurotrophic factor upregulation and sensorimotor gating abnormality induced by postnatal exposure to phencyclidine Reviewed

    Makoto Takahashi, Yuichiro Watanabe, Makoto Mizuno, Kenji Sakimura, Toshitaka Nabeshima, Toshiyuki Someya, Hiroyuki Nawa

    NEUROSCIENCE RESEARCH   55   S12 - S12   2006

     More details

    Language:English  

    Web of Science

    researchmap

  • そこが知りたい薬物療法Q&A Risperidoneは低体温を起こすか?

    坂井 美和子, 渡部 雄一郎, 染矢 俊幸

    臨床精神薬理   8 ( 12 )   1965 - 1966   2005.12

     More details

    Language:Japanese   Publisher:(株)星和書店  

    J-GLOBAL

    researchmap

  • 総合病院精神科におけるコンサルテーション・リエゾン活動 外来患者と入院患者の比較

    坂井 美和子, 渡部 雄一郎, 塩入 俊樹, 諸橋 優子, 田中 弘, 川村 剛, 福島 昇, 染矢 俊幸

    精神科治療学   20 ( 9 )   953 - 959   2005.9

     More details

    Language:Japanese   Publisher:(株)星和書店  

    CiNii Article

    J-GLOBAL

    researchmap

  • 本邦からの報告 第8回 操作的診断(DSMおよびICD)のアウトカム研究に果たす役割

    渡部雄一郎, 染矢俊幸

    Schizophrenia Front   6 ( 3 )   209 - 212   2005.8

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 第7回 統合失調症の仮説とそのモデル検証 炎症性サイトカインと統合失調症;複雑な環境―遺伝子相互作用

    那波宏之, 津田法子, 渡部雄一郎, 任海学, 水野誠

    分子精神医学   5 ( 3 )   301 - 307   2005.7

     More details

  • 【精神科領域の薬学的ケア】 患者を知る・くすりを知る 統合失調症の病態と行動

    渡部 雄一郎, 染矢 俊幸

    薬事   47 ( 8 )   1315 - 1318   2005.7

     More details

    Language:Japanese   Publisher:(株)じほう  

    CiNii Article

    CiNii Books

    J-GLOBAL

    researchmap

  • Perinatal perturbation of inflammatory cytokine activities results in distinct cognitive/behavioral impairments in rodents; Implication in psychiatric diseases of neurodevelopmental origin Reviewed

    H Nawa, M Tohmi, N Tsuda, Y Watanabe, T Someya, M Mizuno

    SCHIZOPHRENIA BULLETIN   31 ( 2 )   306 - 306   2005.4

     More details

    Language:English  

    Web of Science

    researchmap

  • 上皮成長因子ファミリーによるドパミン神経発達調節活性と認知機能障害の関連解析

    岩倉 百合子, 朴 英善, 外山 英和, 渡部 雄一郎, 金 善和, 水野 誠, 那波 宏之

    精神薬療研究年報   ( 37 )   138 - 143   2005.3

     More details

    Language:Japanese   Publisher:(公財)先進医薬研究振興財団  

    J-GLOBAL

    researchmap

  • No association of EGF polymorphism with schizophrenia in a Japanese population Reviewed

    Y Watanabe, N Fukui, T Muratake, N Kaneko, T Someya

    NEUROREPORT   16 ( 4 )   403 - 405   2005.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/00001756-200503150-00019

    Web of Science

    PubMed

    researchmap

  • 治療薬開発の現状と見通し (〔こころの科学〕創刊20周年記念増大号) -- (特別企画 統合失調症)

    渡部 雄一郎, 染矢 俊幸

    こころの科学   ( 120 )   36 - 42   2005.3

     More details

    Language:Japanese   Publisher:日本評論社  

    CiNii Article

    CiNii Books

    researchmap

  • Risperidone投与中に水中毒から悪性症候群と横紋筋融解症を呈した統合失調症の1例

    渡部 雄一郎, 小林 慎一, 熊谷 敬一, 山本 佳子, 田中 敏春, 藤島 直人, 内藤 明彦, 染矢 俊幸

    臨床精神薬理   8 ( 2 )   235 - 239   2005.2

     More details

    Language:Japanese   Publisher:(株)星和書店  

    CiNii Article

    J-GLOBAL

    researchmap

  • Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: implication in psychiatric disorders of developmental origin Reviewed

    M Tohmi, N Tsuda, Y Watanabe, A Kakita, H Nawa

    NEUROSCIENCE RESEARCH   50 ( 1 )   67 - 75   2004.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.neures.2004.05.010

    Web of Science

    PubMed

    researchmap

  • サイトカインを用いた認知障害モデル動物;統合失調症との関連

    那波宏之, 任海学, 津田法子, 渡部雄一郎, 水野誠

    応用薬理   66 ( 3 )   231 - 235   2004.7

     More details

  • Neonatal impact of leukemia inhibitory factor on neurobehavioral development in rats Reviewed

    Y Watanabe, S Hashimoto, A Kakita, H Takahashi, J Ko, M Mizuno, T Someya, PH Patterson, H Nawa

    NEUROSCIENCE RESEARCH   48 ( 3 )   345 - 353   2004.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.neures.2003.12.001

    Web of Science

    PubMed

    researchmap

  • A decrease in interleukin-1 receptor antagonist expression in the prefrontal cortex of schizophrenic patients Reviewed

    K Toyooka, Y Watanabe, S Iritani, E Shimizu, M Iyo, R Nakamura, K Asama, T Makifuchi, A Kakita, H Takahashi, T Someya, H Nawa

    NEUROSCIENCE RESEARCH   46 ( 3 )   299 - 307   2003.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/S0168-0102(03)00093-2

    Web of Science

    PubMed

    researchmap

  • Stress vulnerability of the rats receiving neonatal administration of interleukin-1 Reviewed

    Y Watanabe, M Tohmi, T Someya, H Nawa

    SCHIZOPHRENIA RESEARCH   60 ( 1 )   118 - 118   2003.3

     More details

  • Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients Reviewed

    K Toyooka, K Asama, Y Watanabe, T Muratake, M Takahashi, T Someya, H Nawa

    PSYCHIATRY RESEARCH   110 ( 3 )   249 - 257   2002.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/S0165-1781(02)00127-0

    Web of Science

    PubMed

    researchmap

  • 修正電気けいれん療法がパーキンソン症状と遷延したうつ状態に著効した一例

    阿部亮, 塩入俊樹, 渡部雄一郎, 成瀬聡, 染矢俊幸

    精神科治療学   17 ( 1 )   67 - 73   2002.1

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 薬物依存症の神経科学 5. 依存性薬物と脳内サイトカイン

    那波宏之, 渡部雄一郎, 任海学, 二村隆史

    医学のあゆみ   199 ( 6 )   437 - 440   2001.11

     More details

  • 精神疾患の分子医学 基礎と臨床 基礎 神経栄養因子・サイトカインと精神疾患

    渡部雄一郎, 那波宏之

    現代医療   33 ( 11 )   2697 - 2702   2001.11

     More details

  • Zung自己記入式抑うつ評価尺度および不安評価尺度の臨床的有用性について

    渡部雄一郎, 坂井美和子, 塩入俊樹, 細木俊宏, 染矢俊幸

    臨床精神医学   30 ( 8 )   991 - 996   2001.8

     More details

  • 神経栄養因子・サイトカインと精神疾患 (特集 精神疾患の分子医学--基礎と臨床) -- (基礎)

    渡部 雄一郎, 那波 宏之

    現代医療   33 ( 11 )   2697 - 2702   2001

     More details

    Language:Japanese   Publisher:現代医療社  

    CiNii Article

    CiNii Books

    researchmap

  • 研修医を応援する 処方奏効・失敗例 再発をくり返す双極I型障害の1症例 lithium維持療法の困難さについて

    渡部 雄一郎, 塩入 俊樹, 染矢 俊幸

    臨床精神薬理   2 ( 12 )   1411 - 1416   1999.12

     More details

    Language:Japanese   Publisher:(株)星和書店  

    researchmap

▶ display all

MISC

▶ display all

Presentations

▶ display all

Research Projects

  • Complehensive analysis of de novo variants in families with schizophrenia

    Grant number:24K10703

    2024.4 - 2027.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

      More details

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

    researchmap

  • 統合失調症患者・両親トリオの全エクソーム解析を起点としたリスク遺伝子の同定

    Grant number:19K08067

    2019.4 - 2022.3

    System name:科学研究費助成事業 基盤研究(C)

    Research category:基盤研究(C)

    Awarding organization:日本学術振興会

    渡部 雄一郎

      More details

    Grant amount:\4290000 ( Direct Cost: \3300000 、 Indirect Cost:\990000 )

    researchmap

  • 統合失調症患者のセルフスティグマ低減および就労意識向上を目的としたメソッドの確立

    Grant number:17K12447

    2017.4 - 2020.3

    System name:科学研究費助成事業 基盤研究(C)

    Research category:基盤研究(C)

    Awarding organization:日本学術振興会

    吉井 初美, 萬代 望, 渡部 雄一郎, 内田 知宏, 上埜 高志

      More details

    Grant amount:\3770000 ( Direct Cost: \2900000 、 Indirect Cost:\870000 )

    本研究は、就労をめざす統合失調症を有する人を対象に、セルフスティグマ低減を目的とした心理教育(5回セッション)を受けていただき、その前後に、セルフスティグマを中心とした抑うつなどのアンケート調査を実施する事によって効果を検証するものである。
    昨年度までに心理教育やアンケート調査の内容を確定し倫理審査の準備を進めてきた。
    今年度は、本学及び対象施設(1か所の就労支援事業所)の倫理審査委員会から承認を得て調査を開始した。そして同意の得られた対象者6名に対して、アンケート調査を実施し、5名の方に心理教育を受けていただいた。この間、有害事象が発生することもなく研究を継続できている。
    また、他の施設(1か所の精神科デイケア)においても倫理審査の手続きを終え審査中であり、2か所の他施設(精神科デイケアと就労支援事業所)に研究協力依頼中である。

    researchmap

  • Search for schizophrenia risk gene based on whole-exome sequencing of parent-affected offspring trios, and gene expression analysis of postmortem brains

    Grant number:16K10185

    2016.4 - 2019.3

    System name:Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    Watanabe Yuichiro

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    Aim: Rare variations are suggested to play a role in the genetic etiology of schizophrenia, and to further investigate their role, we performed a three-stage study. Methods: First, we performed whole-exome sequencing (WES) of two parent-affected offspring trios. Second, we sequenced the FBXO18 coding region in 96 patients. Third, we tested rare non-synonymous FBXO18 variations for association with schizophrenia in 1,376 patients and 1,496 controls. Results: A rare frameshift variation (L116fsX) in the FBXO18 gene was recurrently identified by WES in both trios. Sequencing FBXO18 coding regions, we detected three rare non-synonymous variations (V15L, L116fsX and V1006I). However, these rare FBXO18 variations were not significantly associated with and schizophrenia in the case-control study. Conclusion: Our present study does not provide evidence for the contribution of rare non-synonymous FBXO18 variations to the genetic etiology of schizophrenia in the Japanese population.

    researchmap

  • Whole-exome sequencing in three families with affected siblings

    Grant number:25461724

    2013.4 - 2016.3

    System name:Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    Watanabe Yuichiro

      More details

    Grant amount:\4940000 ( Direct Cost: \3800000 、 Indirect Cost:\1140000 )

    To investigate the role of rare inherited variations, we performed whole-exome sequencing (WES) in three families, each with two affected siblings. We also performed a three-stage follow-up case-control study in a Japanese population with a total of 2617 patients and 2396 controls. WES identified 15 rare truncating variations that were variously present in the two affected siblings in each family. In the follow-up study, four variations (NWD1 W169X, LCORL R7fsX53, CAMK2B L497fsX497, and C9orf89 Q102X) had a higher mutant allele frequency in patients compared with controls, although these associations were not significant in the combined population, which comprised the first-, second- and third-stage populations. These results do not support a contribution of the rare truncating variations identified in the three families to the genetic etiology of schizophrenia.

    researchmap

  • Genetic research of schizophrenia and autism

    Grant number:23791312

    2011 - 2012

    System name:Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B)

    Research category:Grant-in-Aid for Young Scientists (B)

    Awarding organization:Japan Society for the Promotion of Science

    WATANABE Yuichiro

      More details

    Grant amount:\4290000 ( Direct Cost: \3300000 、 Indirect Cost:\990000 )

    MicroRNAs may play a role in the pathophysiology of schizophrenia and autism spectrum disorders (ASD). To explore risk variations for schizophrenia and ASD, we resequenced MIR137 and performed an association analysis in 1,502 Japanese individuals. By resequencing, we detected four sequence variations in the 5' and 3' flanking regions. These variations did not associate with schizophrenia and ASD. Our resequencing and association analysis of MIR137 failed to find risk variations for schizophrenia and ASD.

    researchmap

  • Consciousness survey concerning schizophrenia of parents who have junior high school student and high school student and development of educational enlightenment media

    Grant number:22592581

    2010 - 2012

    System name:Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    YOSHII Hatsumi, AKAZAWA Kouhei, TERASIMA Takeshi, KITAMURA Hideaki, WATANABE Yuichiro, GOTO Masahiro

      More details

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

    The knowledge and consciousness concerning schizophrenia was surveyed to parents of the junior and senior high school student. In addition, it had correct knowledge concerning schizophrenia, and an educational enlightenment media to promote the help desire action were made. The program resulted in an improvement in basic knowledge of schizophrenia, discrimination of schizophrenia symptoms, and discrimination of prodromal symptoms (P<0.001 for all). After the education program, the rate of parents who sought medical help within 1 week was significantly higher for sleeplessness and social withdrawal and strange behavior.

    researchmap

  • Comprehensive genetic analysis of CABIN1 in schizophrenia

    Grant number:21791114

    2009 - 2010

    System name:Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B)

    Research category:Grant-in-Aid for Young Scientists (B)

    Awarding organization:Japan Society for the Promotion of Science

    WATANABE Yuichiro

      More details

    Grant amount:\4290000 ( Direct Cost: \3300000 、 Indirect Cost:\990000 )

    The gene encoding calcineurin binding protein 1 (CABIN1) is a promising candidate gene for schizophrenia. To assess whether CABIN1 is implicated in vulnerability to schizophrenia, we conducted a case-control association study between CABIN1 and schizophrenia. The results revealed no evidence of an association between CABIN1 and schizophrenia using 11 tagging single nucleotide polymorphisms and a copy number variation. Our results suggest that CABIN1 may not confer increased susceptibility for schizophrenia.

    researchmap

  • Copy number variation and risk of schizophrenia : a genome-wide analysis in a multiplex pedigree

    Grant number:21791116

    2009 - 2010

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Young Scientists (B)

    Awarding organization:Japan Society for the Promotion of Science

    KANEKO Naoshi, WATANABE Yuichiro, NUNOKAWA Ayako, SOMEYA Toshiyuki

      More details

    Grant amount:\4420000 ( Direct Cost: \3400000 、 Indirect Cost:\1020000 )

    We conducted a genome-wide copy number variation (CNV) screening in a large multiplex schizophrenia pedigree and performed a follow up case-control study. In screening using microarray method, we found a CNV which potentially co-segregated with schizophrenia. We analyzed This CNV by means of a TaqMan real-time PCR assay and found complete deletions of CNVs in five of six affected individuals and an individual with affection status of unknown. We also conducted a case-control study in 627 patients of schizophrenia and 620 healthy controls. There was no significant association between complete deletions of the CNVs and schizophrenia. Taken together, these results suggest that the CNV may not confer increased susceptibility to schizophrenia.

    researchmap

  • Spectroscopy Genomics : Exploring an Effect of Single Nucleotide Polymorphism on Brain Metabolites as Intermediate Phenotypes of Schizophrenia

    Grant number:19591343

    2007 - 2008

    System name:Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    KITAMUR Hideaki, SHI0IRI Toshiki, WATANABE Yuichiro

      More details

    Grant amount:\3120000 ( Direct Cost: \2400000 、 Indirect Cost:\720000 )

    researchmap

  • 統合失調症におけるサイトカイン・神経栄養因子遺伝子の解析

    Grant number:18790825

    2006 - 2007

    System name:科学研究費助成事業 若手研究(B)

    Research category:若手研究(B)

    Awarding organization:日本学術振興会

    渡部 雄一郎

      More details

    Grant amount:\3500000 ( Direct Cost: \3500000 )

    【目的】サイトカインあるいは神経栄養因子の遺伝子は統合失調症の候補遺伝子として注目されている。しかし、これらの候補遺伝子については報告により必ずしも一致した結果が得られていない。そこで今回我々は、サイトカイン・神経栄養因子遺伝子が統合失調症の疾患感受性遺伝子であるか否かを明らかにするために、日本人集団を対象とした関連研究を行った。
    【方法】対象はDSM-IVにより統合失調症と診断された者536人(男性281人、平均年齢40.1[SD 14.2]歳)、および精神疾患既往歴のない健常対象者510人(男性275人、平均年齢37.4[SD 10.2]歳)である。本研究は新潟大学医学部遺伝子倫理審査委員会の承認を得ており、対象者には研究について十分な説明を行い事前に書面にて同意を得ている。
    先行研究で関連を認めた多型に加えHapMapデータに基づいて選択したinterleukin 2 (IL2)遺伝子の3多型およびIL4遺伝子の4多型についてTaqMan法により遺伝子型判定を行った。
    【結果】解析した7多型については、遺伝子型、アレル、ハプロタイプ頻度のいずれも両群間で有意な差を認めなかった。
    【考察】日本人においては、これらのIL2およびIL4遺伝子と統合失調症との関連は否定的であり、先行研究との結果の相違は民族差を反映したものと考えられる。ただし、第2種の過誤の可能性を完全に否定することはできず、さらにサンプル・サイズを増やした研究やメタ解析が望まれる。

    researchmap

▶ display all

 

Teaching Experience

  • 健康スポーツ科学講義

    2012
    Institution name:新潟大学

  • 健康と医学

    2010
    -
    2012
    Institution name:新潟大学